pdf,doi,doi_sourse,supplementary,title,publisher,year,access,compound_id,compound_name,SMILES,SMILES_type,metal,target,page_smiles,origin_smiles,page_metal,origin_metal,page_target_value,origin_target_value
wadas2010,10.1021/cr900325h,10.1002/ejic.200401036,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L1,,O=C(O)CN(CC(=O)O)Cc1cc([N+](=O)[O-])ccc1O,ligand,Ga,"19,1",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/ic980227j,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L2,,Sc1ccccc1CN(Cc1ccccc1S)Cc1ccccc1S,ligand,Ga,"20,5",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/ic951535%2B,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L4,BAT-TM,CC(C)(S)CNCCNCC(C)(C)S,ligand,Ga,,6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/ic941330l,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L5,EC,O=C(O)CC(CS)NCCNC(CS)CC(=O)O,ligand,Ga,"31,5",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1016/S0039-9140(97)00157-4,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L10,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Ga,21,6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1007/978-1-4615-6764-6,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L10,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Ga,22,6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1016/0020-1693(94)04012-5,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L11,HBED,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)Cc1ccccc1O,ligand,Ga,"37,7",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/ic00007a024,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L11,HBED,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)Cc1ccccc1O,ligand,Ga,"38,5",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1007/978-1-4615-6764-6,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L12,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Ga,"25,5",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/ic951019j,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L15,SBAD,O=S(=O)([O-])c1ccc(O)c(CCCCNCCNCCNCc2cc(S(=O)(=O)[O-])ccc2O)c1,ligand,Ga,"28,3",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1016/S1074-5521(00)00111-3,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L16,BAPEN,Oc1ccccc1C=NCCCNCCNCCCN=Cc1ccccc1O,ligand,Ga,,6,figure 2,12,table 5 (caption),,
wadas2010,10.1021/cr900325h,10.1080/10610279608032555,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L29,NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,31,7,figure 3,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/ic00067a022,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L29,NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,31,7,figure 3,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1080/10610279608032555,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L27,TACN-TM,SCCN1CCN(CCS)CCN(CCS)CC1,ligand,Ga,"34,2",7,figure 3,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1080/10610279608032555,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L39,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,"21,3",7,figure 3,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1080/10610279608032555,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L49,TETA,O=C(O)CN1CCCN(CC(=O)O)CCN(CC(=O)O)CCCN(CC(=O)O)CC1,ligand,Ga,"19,7",7,figure 3,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1002/ejic.200400075,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L37,CB-DO2A,O=C(O)CN1CCN2CCN(CC1)CCN(CC(=O)O)CC2,ligand,Ga,,7,figure 3,12,table 5 (caption),,
wadas2010,10.1021/cr900325h,10.1021/cr900325h,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L57,CB-TE2A,O=C(O)CN1CCCN2CCN(CCCN(CC(=O)O)CC2)CC1,ligand,Ga,,7,figure 3,12,table 5 (caption),,
wadas2010,10.1021/cr900325h,10.1016/0047-0740(81)90034-6,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L20,DiP-LICAM,CC(C)N(CCCCN(CCCN(C(=O)c1cccc(O)c1O)C(C)C)C(=O)c1cccc(O)c1O)C(=O)c1cccc(O)c1O,ligand,Ga,"38,6",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/cr900325h,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L66,,CC12COCCC(=O)N(O)CCOCC(C)(COCCN(O)C(=O)CCOC1)COCCN(O)C(=O)CCOC2,ligand,Ga,"27,5",7,figure 3,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/ic00013a007,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L21,,CN(O)C(=O)CCOCC(C)(COCCC(=O)N(C)O)COCCC(=O)N(C)O,ligand,Ga,"25,6",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/cr900325h,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L22,,CN(O)C(=O)CCCOCC(C)(COCCCC(=O)N(C)O)COCCCC(=O)N(C)O,ligand,Ga,"27,3",6,figure 2,12,table 5 (caption),12,table 5
wadas2010,10.1021/cr900325h,10.1021/ic00310a035,0,"Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease",American Chemical Society (ACS),2010,1,L23,DFO,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,ligand,Ga,"28,6",6,figure 2,12,table 5 (caption),12,table 5
kubicek2010,10.1021/ic101378s,10.1021/ic101378s,0,Gallium(III) Complexes of DOTA and DOTA−Monoamide: Kinetic and Thermodynamic Studies,American Chemical Society (ACS),2010,0,,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,"26,05",2,chart 1,1,title,2,table 2
kubicek2010,10.1021/ic101378s,10.1021/ic101378s,0,Gallium(III) Complexes of DOTA and DOTA−Monoamide: Kinetic and Thermodynamic Studies,American Chemical Society (ACS),2010,0,,DO3AMBu,CCCCNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,"24,64",2,chart 1,1,title,2,table 2
kubicek2010,10.1021/ic101378s,10.1021/ic101378s,0,Gallium(III) Complexes of DOTA and DOTA−Monoamide: Kinetic and Thermodynamic Studies,American Chemical Society (ACS),2010,0,,NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,,2,chart 1,1,title,,
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,"26,1",2,figure 1,1,title,2,section 1 (text)
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,"29,6",2,figure 1,1,title,2,section 1 (text)
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,NOTAMBP,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)NC(P(=O)(O)O)P(=O)(O)O)CC1,ligand,Ga,,2,figure 1,1,title,,
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,NO2APBP,O=C(O)CN1CCN(CC(=O)O)CCN(CP(=O)(O)CC(P(=O)(O)O)P(=O)(O)O)CC1,ligand,Ga,,2,figure 1,1,title,,
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,NO2AP,O=C(O)CN1CCN(CC(=O)O)CCN(CP(=O)(O)O)CC1,ligand,Ga,,2,figure 1,1,title,,
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,NO1A2P,O=C(O)CN1CCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CC1,ligand,Ga,,2,figure 1,1,title,,
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,DO3APBP,O=C(O)CN1CCN(CC(=O)O)CCN(CP(=O)(O)CC(P(=O)(O)O)P(=O)(O)O)CCN(CC(=O)O)CC1,ligand,Ga,,2,figure 1,1,title,,
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,DOTAMBP,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)NC(P(=O)(O)O)P(=O)(O)O)CCN(CC(=O)O)CC1,ligand,Ga,,2,figure 1,1,title,,
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,EDTMP,O=P(O)(O)CN(CCN(CP(=O)(O)O)CP(=O)(O)O)CP(=O)(O)O,ligand,Ga,,2,figure 1,1,title,,
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,MDP,O=P(O)(O)CP(=O)(O)O,ligand,Ga,,2,figure 1,1,title,,
holub2013,10.1002/cmmi.1606,10.1002/cmmi.1606,0,Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging,Wiley,2015,0,,NOTAGA,O=C(O)CCC(C(=O)O)N1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,,2,figure 1,1,title,,
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,HIDA,O=C(O)CN(CCO)CC(=O)O,ligand,Ga,"11,33",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,IDA,O=C(O)CNCC(=O)O,ligand,Ga,"12,76",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,NTA,O=C(O)CN(CC(=O)O)CC(=O)O,ligand,Ga,"16,19",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,UEDDA,NCCN(CC(=O)O)CC(=O)O,ligand,Ga,"16,75",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,HEDTA,O=C(O)CN(CCO)CCN(CC(=O)O)CC(=O)O,ligand,Ga,"17,2",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,TEDTA,O=C(O)CN(CCSCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Ga,"17,3",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,SEDDA,O=C(O)CNCCNCC(=O)O,ligand,Ga,"18,15",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,tiron,O=S(=O)(O)c1cc(O)c(O)c(S(=O)(=O)O)c1,ligand,Ga,"19,4",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,TMDTA,O=C(O)CN(CCCCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Ga,"20,8",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,EEDTA,O=C(O)CN(CCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Ga,21,2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Ga,"21,7",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,CDTA,O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Ga,"22,34",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Ga,"23,32",2,figure 1,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,HIBDA,O=C(O)CN(CC(=O)O)Cc1cccc(O)c1,ligand,Ga,,2,figure 1,1,title,,
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,EHPG,O=C(O)C(NCCNC(C(=O)O)c1ccccc1O)c1ccccc1O,ligand,Ga,"31,61",7,figure 5,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,PLED,Cc1ncc(CO)c(CN(CCN(CC(=O)O)Cc2c(CO)cnc(C)c2O)CC(=O)O)c1O,ligand,Ga,"36,35",7,figure 5,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,HBED,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)Cc1ccccc1O,ligand,Ga,"39,57",7,figure 5,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,t-butyl HBED,Cc1cc(C(C)(C)C)cc(CN(CCN(CC(=O)O)Cc2cc(C(C)(C)C)cc(C)c2O)CC(=O)O)c1O,ligand,Ga,,7,figure 5,1,title,,
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,Me4HBED,Cc1cc(C)c(O)c(CN(CCN(CC(=O)O)Cc2cc(C)cc(C)c2O)CC(=O)O)c1,ligand,Ga,,7,figure 5,1,title,,
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,HBMA,Cc1cc(C)c(O)c(CN(CCO)CCN(CC(=O)O)Cc2cc(C)cc(C)c2O)c1,ligand,Ga,,7,figure 5,1,title,,
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,SHBED,O=C(O)CN(CCN(CC(=O)O)Cc1cc(S(=O)(=O)[O-])ccc1O)Cc1cc(S(=O)(=O)[O-])ccc1O,ligand,Ga,,7,figure 5,1,title,,
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,DPLED,Cc1cnc(C)c(O)c1CN(CCN(CC(=O)O)Cc1c(C)cnc(C)c1O)CC(=O)O,ligand,Ga,,7,figure 5,1,title,,
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,"3,4-DiP-LICAM",CC(C)N(CCCCN(CCCN(C(=O)c1cccc(O)c1O)C(C)C)C(=O)c1cccc(O)c1O)C(=O)c1cccc(O)c1O,ligand,Ga,"38,6",6,figure 4,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,TiP-MECAMS,CC(C)N(Cc1cc(CN(C(=O)c2cc(S(=O)(=O)O)cc(O)c2O)C(C)C)cc(CN(C(=O)c2cc(S(=O)(=O)O)cc(O)c2O)C(C)C)c1)C(=O)c1cc(S(=O)(=O)O)cc(O)c1O,ligand,Ga,42,6,figure 4,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,"3,4-DiP-LICAMS",CC(C)N(CCCCN(CCCN(C(=O)c1cc(S(=O)(=O)O)cc(O)c1O)C(C)C)C(=O)c1cc(S(=O)(=O)O)cc(O)c1O)C(=O)c1cc(S(=O)(=O)O)cc(O)c1O,ligand,Ga,"42,1",6,figure 4,1,title,2,table 2
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,desferrioxamine,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(O)N(O)CCCCCN,ligand,Ga,,6,figure 4,1,title,,
green1989,10.1016/0883-2897(89)90053-6,10.1016/0883-2897(89)90053-6,0,Gallium radiopharmaceutical chemistry,Elsevier BV,1989,0,,enterobactin,O=C(NC1COC(=O)C(NC(=O)c2cccc(O)c2O)COC(=O)C(NC(=O)c2cccc(O)c2O)COC1=O)c1cccc(O)c1O,ligand,Ga,52,6,figure 4,1,title,7,text
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/jm9505977,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Ga,"24,3",3,table 1,1,title,3,table 1
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/ic00310a035,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DFO,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,ligand,Ga,"28,6",3,table 1,1,title,3,table 1
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/ja106399h,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,H2dedpa,O=C(O)c1cccc(CNCCNCc2cccc(C(=O)O)n2)n1,ligand,Ga,"28,1",3,table 1,1,title,3,table 1
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/0020-1693(94)04012-5,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,HBED,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)Cc1ccccc1O,ligand,Ga,"38,5",3,table 1,1,title,3,table 1
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1039/C1CC12123E,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,H3THP-Ac,CC(=O)NC(CCC(=O)NCc1[nH]c(C)cc(=O)c1O)(CCC(=O)NCc1c(O)c(=O)cc(C)n1C)CCC(=O)NCc1c(O)c(=O)cc(C)n1C,ligand,Ga,,3,table 1,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/S0020-1693(00)80229-7,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,"21,3",3,table 1,1,title,3,table 1
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/S0020-1693(00)86821-8,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,31,3,table 1,1,title,3,table 1
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1002/ejic.201201108,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,AAZTA,CC1(N(CC(=O)O)CC(=O)O)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Ga,"22,2",4,table 1,1,title,4,table 1
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1002/cmdc.201500092,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DATAm,CN(CC(=O)O)C1(C)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Ga,"21,7",4,table 1,1,title,4,table 1
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/bc200319q,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,(NH2)2-sar,NC12CNCCNCC(N)(CNCCNC1)CNCCNC2,ligand,Ga,,4,table 1,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1002/jlcr.3286,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,Fusarinine C,CC1=CC(=O)N(O)CCCC(N)C(=O)OCCC(C)=CC(=O)N(O)CCCC(N)C(=O)OCCC(C)=CC(=O)N(O)CCCC(N)C(=O)OCC1,ligand,Ga,,4,table 1,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/j.apradiso.2011.11.054,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,Porphyrins,C=CC1=C(C)c2cc3nc(cc4[nH]c(cc5[nH]c(cc1n2)c(C)c5C=C)c(C)c4CCC(=O)O)C(CCC(=O)O)=C3C,ligand,Ga,,4,table 1,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1007/BF00252997,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,CA-DTPA,O=C(O)CN(CCN1CC(=O)OC(=O)C1)CCN1CC(=O)OC(=O)C1,ligand,Ga,,5,table 2,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/j.nucmedbio.2012.11.001,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,p-SCN-DTPA,N#CSc1ccc(CC(CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)cc1,ligand,Ga,,5,table 2,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1053/j.semnuclmed.2016.04.003,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,p-NH2Bn-DTPA,Nc1ccc(CC(CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)cc1,ligand,Ga,,5,table 2,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.3390/ph7050517,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,p-SCN-Bn-CHX-A-DTPA,N#CSc1ccc(CC(CN(CC(=O)O)C2CCCCC2N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)cc1,ligand,Ga,,5,table 2,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1524/ract.2007.95.1.39,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,1B4M-DTPA,CC(CN(CC(=O)O)CC(Cc1ccc(SC#N)cc1)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Ga,,5,table 2,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/0022-1759(87)90492-3,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DFO-Mal,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCN1C(=O)C=CC1=O,ligand,Ga,,6,table 3,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1007/s00259-010-1700-1,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,p-SCN-Bn-DFO,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=S)Nc1ccc(SC#N)cc1,ligand,Ga,,6,table 3,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1039/B924784J,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,Click DFO,C#CCNC(=S)Nc1ccc(NC(=S)NCCCCCN(O)C(=O)CCC(=O)NCCCCCN(O)C(=O)CCC(=O)NCCCCCN(O)C(C)=O)cc1,ligand,Ga,,6,table 3,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/j.nucmedbio.2009.11.010,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DFO-CHX-Mal,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)C1CCC(CN2C(=O)C=CC2=O)CC1,ligand,Ga,,6,table 3,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1053/j.semnuclmed.2016.04.003,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DFO-Iac,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CI,ligand,Ga,,6,table 3,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1053/j.semnuclmed.2016.04.003,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DFO-Bac,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CBr,ligand,Ga,,6,table 3,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/j.nucmedbio.2012.01.003,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,H2-dp-bb-NCS,N#CSc1ccc(CC(CNCc2cccc(C(=O)O)n2)NCc2cccc(C(=O)O)n2)cc1,ligand,Ga,,7,table 4,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/j.nucmedbio.2012.01.003,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,H2-dp-NCS,N#CSc1ccc(CN(CCN(Cc2ccc(SC#N)cc2)Cc2cccc(C(=O)O)n2)Cc2cccc(C(=O)O)n2)cc1,ligand,Ga,,7,table 4,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/ic302225z,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,H2azapa,O=C(O)c1cccc(CN(CCN(Cc2cn(Cc3ccccc3)nn2)Cc2cccc(C(=O)O)n2)Cc2cn(Cc3ccccc3)nn2)n1,ligand,Ga,,7,table 4,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/j.nucmedbio.2010.02.001,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,HBED-CC,O=C(O)CCc1ccc(O)c(CN(CCN(CC(=O)O)Cc2cc(CCC(=O)O)ccc2O)CC(=O)O)c1,ligand,Ga,,8,table 5,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1053/j.semnuclmed.2016.04.003,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,HBED-CA,NCCc1ccc(O)c(CN(CCN(CC(=O)O)Cc2cc(CCC(=O)O)ccc2O)CC(=O)O)c1,ligand,Ga,,8,table 5,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1053/j.semnuclmed.2016.04.003,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,HBED-CI,O=C(O)CCc1ccc(O)c(CN(CCN(CC(=O)O)Cc2cc(CCN=C=S)ccc2O)CC(=O)O)c1,ligand,Ga,,8,table 5,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1053/j.semnuclmed.2016.04.003,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,HBED-AA,NCCc1ccc(O)c(CN(CCN(CC(=O)O)Cc2cc(CCN)ccc2O)CC(=O)O)c1,ligand,Ga,,8,table 5,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.3390/ph7070779,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,HBED-CC-TPF,O=C(O)CCc1ccc(O)c(CN(CCN(CC(=O)O)Cc2cc(CCC(=O)Oc3c(F)c(F)cc(F)c3F)ccc2O)CC(=O)O)c1,ligand,Ga,,8,table 5,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.3390/ph7070779,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,HBED-CC-TPF2,O=C(O)CN(CCN(CC(=O)O)Cc1cc(CCC(=O)Oc2c(F)c(F)cc(F)c2F)ccc1O)Cc1cc(CCC(=O)Oc2c(F)c(F)cc(F)c2F)ccc1O,ligand,Ga,,8,table 5,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1039/C4DT02978J,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,H3THP-Mal,Cc1cc(=O)c(O)c(CNC(=O)CCC(CCC(=O)NCc2c(O)c(=O)cc(C)n2C)(CCC(=O)NCc2c(O)c(=O)cc(C)n2C)NC(=O)CCNC(=O)CCN2C(=O)C=CC2=O)[nH]1,ligand,Ga,,10,table 6,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/acs.bioconjchem.5b00335,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,H3THP-NCS,Cc1cc(=O)c(O)c(CNC(=O)CCC(CCC(=O)NCc2c(O)c(=O)cc(C)n2C)(CCC(=O)NCc2c(O)c(=O)cc(C)n2C)NC(=O)CCSC#N)[nH]1,ligand,Ga,,10,table 6,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/acs.bioconjchem.5b00335,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,H3THP-PhNCS,Cc1cc(=O)c(O)c(CNC(=O)CCC(CCC(=O)NCc2c(O)c(=O)cc(C)n2C)(CCC(=O)NCc2c(O)c(=O)cc(C)n2C)NC(=O)CCNC(=S)Nc2ccc(SC#N)cc2)[nH]1,ligand,Ga,,11,table 6,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1007/s00259-008-0757-6,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DOTA-tris(t-Bu),CC(C)(C)OC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)OC(C)(C)C)CCN(CC(=O)OC(C)(C)C)CC1,ligand,Ga,,11,table 7,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/bc800538s,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DOTA-NHS,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)ON2C(=O)CCC2=O)CCN(CC(=O)O)CC1,ligand,Ga,,11,table 7,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/ol100774p,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,Clickable DOTA,[N-]=[N+]=NCCCNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,,11,table 7,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1002/chem.201200132,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DOTAGA-anhydride,O=C(O)CN1CCN(CC(=O)O)CCN(C2CCC(=O)OC2=O)CCN(CC(=O)O)CC1,ligand,Ga,,11,table 7,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/bc900443a,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,oxo-DO3A,O=C(O)CN1CCOCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,,12,table 7,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/bc900443a,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,PCTA,O=C(O)CN1CCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CC1,ligand,Ga,,12,table 7,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/bc900443a,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,p-SCN-Bn-DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)C(Cc2ccc(N=C=S)cc2)CN(CC(=O)O)CC1,ligand,Ga,,12,table 7,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/bc900443a,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,p-NH2-Bn-DOTA,Nc1ccc(CC2CN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN2CC(=O)O)cc1,ligand,Ga,,12,table 7,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/bc010074f,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,NODAGA,O=C(O)CCC(C(=O)O)N1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,,13,table 8,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1039/A801294F,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,NODASA,O=C(O)CC(C(=O)O)N1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,,13,table 8,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.2967/jnumed.107.047423,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,p-SCN-benzyl NOTA,N#CSc1ccc(CC2CN(CC(=O)O)CCN(CC(=O)O)CCN2CC(=O)O)cc1,ligand,Ga,,13,table 8,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1002/chem.200903281,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,TRAP,O=C(O)CCP(=O)(O)CN1CCN(CP(=O)(O)CCC(=O)O)CCN(CP(=O)(O)CCC(=O)O)CC1,ligand,Ga,,13,table 8,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1021/mp400642s,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,NOPO,O=C(O)CCP(=O)(O)CN1CCN(CP(=O)(O)CO)CCN(CP(=O)(O)CO)CC1,ligand,Ga,,13,table 8,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1186/s13550-015-0154-7,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,AAZTA-C9,O=C(O)CCCCCCCCCC1(N(CC(=O)O)CC(=O)O)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Ga,,14,table 9,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1002/cmdc.201200043,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,AAZTA-C4,O=C(O)CCCCC1(N(CC(=O)O)CC(=O)O)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Ga,,14,table 9,1,title,,
spang2016,10.1053/j.semnuclmed.2016.04.003,10.1016/j.apradiso.2015.01.023,0,"Bifunctional Gallium-68 Chelators: Past, Present, and Future",Elsevier BV,2016,0,,DATA5m,CN(CC(=O)O)C1(CCCCC(=O)O)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Ga,,14,table 9,1,title,,
mcinnes2017,10.1016/j.ccr.2017.05.011,10.1021/jm9505977,0,"Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation",Elsevier BV,2017,0,,6SS,CC(C)(S)CN(CCN(CC(C)(C)S)C(=O)O)C(=O)O,ligand,Ga,,10,figure 7,7,subtitle 3,,
mcinnes2017,10.1016/j.ccr.2017.05.011,10.1007/s00259-008-0816-z,0,"Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation",Elsevier BV,2017,0,,HBED,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)Cc1ccccc1O,ligand,Ga,,10,figure 7,7,subtitle 3,,
mcinnes2017,10.1016/j.ccr.2017.05.011,10.1007/s00259-011-1778-0,0,"Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation",Elsevier BV,2017,0,,NODAGA,O=C(O)CCC(C(=O)O)N1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,,10,figure 7,7,subtitle 3,,
mcinnes2017,10.1016/j.ccr.2017.05.011,10.1007/s00259-004-1702-y,0,"Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation",Elsevier BV,2017,0,,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,,6,figure 3,7,subtitle 3,,
mcinnes2017,10.1016/j.ccr.2017.05.011,10.1021/bc200319q,0,"Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation",Elsevier BV,2017,0,,(CO2H)2sar,O=C(O)CCCC(=O)NC12CNCCNCC(NC(=O)CCCC(=O)O)(CNCCNC1)CNCCNC2,ligand,Ga,,10,figure 7,7,subtitle 3,,
mcinnes2017,10.1016/j.ccr.2017.05.011,10.1038/nprot.2008.22,0,"Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation",Elsevier BV,2017,0,,DFO,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,ligand,Ga,,10,figure 7,7,subtitle 3,,
mcinnes2017,10.1016/j.ccr.2017.05.011,10.1007/s00259-013-2397-8,0,"Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation",Elsevier BV,2017,0,,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Ga,,10,figure 7,7,subtitle 3,,
mcinnes2017,10.1016/j.ccr.2017.05.011,10.1021/acs.bioconjchem.5b00335,0,"Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation",Elsevier BV,2017,0,,YM103,Cc1cc(=O)c(O)c(CNC(=O)CCC(CCC(=O)NCc2c(O)c(=O)cc(C)n2C)(CCC(=O)NCc2c(O)c(=O)cc(C)n2C)NC(=O)CCNC(=O)CCN2C(=O)C=CC2=O)n1C,ligand,Ga,,10,figure 7,7,subtitle 3,,
mcinnes2017,10.1016/j.ccr.2017.05.011,10.1021/acs.bioconjchem.5b00335,0,"Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation",Elsevier BV,2017,0,,c(RGDfK),N=C(N)NCCCC1NC(=O)C(CCCCN)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(=O)O)NC(=O)CNC1=O,ligand,Ga,,10,figure 7,7,subtitle 3,,
price2016,10.1039/c5dt04706d,10.1021/cr900325h,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,31,4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1021/cr900325h,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TACN-TM,SCN1CCN(CS)CCN(CS)CC1,ligand,Ga,"34,2",4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1021/ic101378s,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,"26,1",4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1021/cr900325h,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TETA,O=C(O)CN1CCCN(CC(=O)O)CCN(CC(=O)O)CCCN(CC(=O)O)CC1,ligand,Ga,"19,7",4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1016/S0039-9140(97)00157-4,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,EDTA,O=C(O)CN(CCN(CC(=O)O)C(=O)O)C(=O)O,ligand,Ga,22,4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1021/jm9505977,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,ED2A2M,CC(C)(S)N(CCN(CC(=O)O)C(C)(C)S)CC(=O)O,ligand,Ga,"31,6",4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1021/cr900325h,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,HBED,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)Cc1ccccc1O,ligand,Ga,"37,7",4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1021/ic941330l,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,EC,O=C(O)C(CS)NCCNC(CS)C(=O)O,ligand,Ga,"31,5",4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1016/S0039-9140(97)00157-4,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Ga,"25,1",4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1021/ic951019j,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,SBAD,O=S(=O)=C1C=CC(O)=C(CNCCNCCNCCNCC2=C(O)C=CC(=S(=O)=O)C2)C1,ligand,Ga,"28,3",4,figure 2,4,table 3 (caption),4,table 3
price2016,10.1039/c5dt04706d,10.1021/ic202103v,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TRAP-OH,O=P(O)(CO)CN1CCN(CP(=O)(O)CO)CCN(CP(=O)(O)CO)CC1,ligand,Ga,"23,3",5,figure 3,4,table 3 (caption),6,table 4
price2016,10.1039/c5dt04706d,10.1002/chem.201103503,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TRAP-Ph,O=P(O)(CN1CCN(CP(=O)(O)c2ccccc2)CCN(CP(=O)(O)c2ccccc2)CC1)c1ccccc1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1002/chem.200903281,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TRAP-Pr,O=C(O)CCP(=O)(O)CN1CCN(CP(=O)(O)CCC(=O)O)CCN(CP(=O)(O)CCC(=O)O)CC1,ligand,Ga,"26,2",5,figure 3,4,table 3 (caption),6,table 4
price2016,10.1039/c5dt04706d,10.1002/chem.201302751,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TRAP-(HMDA-DOTA)3,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)NCCCCCCNC(=O)CCP(=O)(O)CN2CCN(CP(=O)(O)CCC(=O)NCCCCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)CCN(CP(=O)(O)CCC(=O)NCCCCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)CC2)CCN(CC(=O)O)CC1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1021/mp400642s,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,NOPO,O=C(O)CCP(=O)(O)CN1CCN(CP(=O)(O)CO)CCN(CP(=O)(O)CO)CC1,ligand,Ga,25,5,figure 3,4,table 3 (caption),6,table 4
price2016,10.1039/c5dt04706d,10.1021/bc900443a,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,PCTA,O=C(O)CN1CCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CC1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1021/bc900443a,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,Oxo,O=C(O)CN1CCOCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1021/bc200319q,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,(NH2)2Sar,NC12CNCCNCC(N)(CNCCNC1)CNCCNC2,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1016/j.nucmedbio.2012.11.006,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,L1,,CC1=C(CCC(=O)O)c2cc3[nH]c(cc4[nH]c(cc5nc(cc1n2)C(C(C)O)=C5C)c(C(C)O)c4C)c(C)c3CCC(=O)O,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1016/j.nucmedbio.2012.11.006,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,L2,,CCC1=C(C)c2cc3[nH]c(cc4[nH]c(cc5nc(cc1n2)C(C)=C5CCC(=O)O)c(CCC(=O)O)c4C)c(C)c3CC,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1016/j.nucmedbio.2012.11.006,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,L3,,C1=Cc2nc1c(-c1ccccc1)c1nc(c(-c3ccccc3)c3ccc([nH]3)c(-c3ccccc3)c3ccc([nH]3)c2-c2ccccc2)C=C1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1016/j.nucmedbio.2012.11.006,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,L4,,CCCCCCC(O)c1c(C)c2cc3[nH]c(cc4nc(cc5nc(cc1[nH]2)C(C)=C5CC)C(C)=C4CCC(=O)OC)c(CCC(=O)OC)c3C,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1016/j.nucmedbio.2012.11.006,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,L5,,COC(=O)CCC1=C(C)c2cc3nc(cc4[nH]c(cc5[nH]c(cc1n2)c(CCC(=O)OC)c5C)C(C)(CC(=O)OC)C4=O)C(C)=C3,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-014-0760-1,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TeMP,C[n+]1ccc(-c2c3nc(c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4nc2C=C4)C=C3)cc1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1039/C4DT02949F,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TriMPN3,C[n+]1ccc(-c2c3nc(c(-c4ccc(N=[N+]=[N-])cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4nc2C=C4)C=C3)cc1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1039/C4DT02949F,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TriMPEG,C[n+]1ccc(-c2c3nc(c(-c4ccc(C(=O)NCCOCCOCCN=[N+]=[N-])cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4nc2C=C4)C=C3)cc1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s13139-011-0109-5,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TFPP,Fc1c(F)c(F)c(-c2c3nc(c(-c4c(F)c(F)c(F)c(F)c4F)c4ccc([nH]4)c(-c4c(F)c(F)c(F)c(F)c4F)c4nc(c(-c5c(F)c(F)c(F)c(F)c5F)c5ccc2[nH]5)C=C4)C=C3)c(F)c1F,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1002/jlcr.3286,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,FSC,CC1=CC(=O)N(O)CCCC(N)C(=O)OCCC(C)=CC(=O)N(O)CCCC(N)C(=O)OCCC(C)=CC(=O)N(O)CCCC(N)C(=O)OCC1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.2967/jnumed.109.072462,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,TAFC,CC(=O)NC1CCCN(O)C(=O)C=C(C)CCOC(=O)C(NC(C)=O)CCCN(O)C(=O)C=C(C)CCOC(=O)C(NC(C)=O)CCCN(O)C(=O)C=C(C)CCOC1=O,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1016/j.nucmedbio.2011.09.012,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,FOXE,O=C1CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN1,ligand,Ga,,5,figure 3,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1021/ja106399h,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,H2dedpa,O=C(O)c1cccc(CNCCNCc2cccc(C(=O)O)n2)n1,ligand,Ga,"28,11",7,figure 4,4,table 3 (caption),9,table 5
price2016,10.1039/c5dt04706d,10.1021/ic502942a,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,H2CHXdedpa,O=C(O)c1cccc(CNC2CCCCC2NCc2cccc(C(=O)O)n2)n1,ligand,Ga,"27,61",7,figure 4,4,table 3 (caption),9,table 5
price2016,10.1039/c5dt04706d,10.1021/ja106399h,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,H2azapa,O=C(O)c1cccc(CN(CCN(Cc2cn(Cc3ccccc3)nn2)Cc2cccc(C(=O)O)n2)Cc2cn(Cc3ccccc3)nn2)n1,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1021/ic502942a,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,H4AAZTA,CC1(N(CC(=O)O)CC(=O)O)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Ga,"22,2",7,figure 4,4,table 3 (caption),9,table 5
price2016,10.1039/c5dt04706d,10.1002/cmdc.201500092,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,DATAM,CN(CC(=O)O)C1(C)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1002/cmdc.201500092,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,DATAP,CC(NC1(C)CN(C(C)C(=O)O)CCN(C(C)C(=O)O)C1)C(=O)O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1002/cmdc.201500092,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,DATAPh,O=C(O)CNC1(c2ccccc2)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1002/cmdc.201500092,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,DATAPPh,CC(NC1(c2ccccc2)CN(C(C)C(=O)O)CCN(C(C)C(=O)O)C1)C(=O)O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1039/C4DT02274B,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,H2LpzNH,Oc1ccccc1CNCN(CCn1cccn1)CNCc1ccccc1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1039/C4DT02274B,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,H2LpyNH,Oc1ccccc1CNCN(CNCc1ccccc1O)Cc1ccccn1,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1039/C1CC12123E,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,CP256,CC(=O)NC(CCC(=O)NCc1c(O)c(=O)cc(C)n1C)(CCC(=O)NCc1c(O)c(=O)cc(C)n1C)CCC(=O)NCc1c(O)c(=O)cc(C)n1C,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1039/C1DT10126A,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,H2ATSM,CNC(S)=NN=C(C)C(C)=NN=C(S)NC,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1039/C1DT10126A,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,H2ATSMNa,CNC(S)=NN=C1C(=NN=C(S)NC)c2cccc3cccc1c23,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-014-0750-3,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,BADED-2,COc1cccc(C=NCC(C)(C)CN2CCN(CC(C)(C)CN=Cc3cccc(OC)c3O)C2c2cccc(OC)c2O)c1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-014-0750-3,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,BADED-3,CC(C)(CN=Cc1cc(Br)ccc1O)CN1CCN(CC(C)(C)CN=Cc2cc(Br)ccc2O)C1c1cc(Br)ccc1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-014-0750-3,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,BADED-4,CC(C)(CN=Cc1ccccc1O)CN1CCN(CC(C)(C)CN=Cc2ccccc2O)C1c1ccccc1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-014-0750-3,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,BADED-5,CCOc1cccc(C=NCC(C)(C)CN2CCN(CC(C)(C)CN=Cc3cccc(OCC)c3O)C2c2cccc(OCC)c2O)c1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-014-0750-3,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,BADED-6,CC(C)(CN=Cc1cc([N+](=O)[O-])ccc1O)CN1CCN(CC(C)(C)CN=Cc2cc([N+](=O)[O-])ccc2O)C1c1cc([N+](=O)[O-])ccc1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-014-0750-3,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,BADED-7,CCN(CC)c1cccc(C=NCC(C)(C)CN2CCN(CC(C)(C)CN=Cc3cccc(N(CC)CC)c3O)C2c2cccc(N(CC)CC)c2O)c1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-014-0750-3,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,BADED-8,COc1cc(Br)cc(C=NCC(C)(C)CN2CCN(CC(C)(C)CN=Cc3cc(Br)cc(OC)c3O)C2c2cc(Br)cc(OC)c2O)c1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-014-0750-3,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,BADED-9,CC(C)(CN=Cc1cc(C(C)(C)C)ccc1O)CN1CCN(CC(C)(C)CN=Cc2cc(C(C)(C)C)ccc2O)C1c1cc(C(C)(C)C)ccc1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
price2016,10.1039/c5dt04706d,10.1007/s11307-010-0410-1,0,"Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>Sc",Royal Society of Chemistry (RSC),2016,0,,MFL3MZ,CC(C)(CN=Cc1cc(C(C)(C)C)cc(C(C)(C)C)c1O)CN1CCN(CC(C)(C)CN=Cc2cc(C(C)(C)C)cc(C(C)(C)C)c2O)C1c1cc(C(C)(C)C)cc(C(C)(C)C)c1O,ligand,Ga,,7,figure 4,4,table 3 (caption),,
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejic.200901261,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A1,H5DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,03",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/mrm.1910080208,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A1,,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,26",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/0022-1902(62)80236-x,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A1,,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,46",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0010-8545(99)00237-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A2,,O=C(O)CCC(C(=O)O)N(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"21,66",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0010-8545(99)00237-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A3,,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)C(COCc1ccccc1)C(=O)O)CC(=O)O,ligand,Gd,"22,23",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/jm9602118,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A4,,Nc1ccc(CC(C(=O)O)N(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O)cc1,ligand,Gd,22,3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic800512k,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A5,,CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"18,6",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00212a005,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A6,,CCN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"17,79",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/cmmi.131,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A7,,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CP(=O)(O)O)CC(=O)O,ligand,Gd,"22,79",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/cmmi.131,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A8,,NCCC(N(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O)P(=O)(O)O,ligand,Gd,"22,34",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1039/b005298l,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A9,,CNC(=O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"19,9",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0277-5387(00)00502-7,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A10,,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)Cc1ccccn1)CC(=O)O,ligand,Gd,"21,59",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0010-8545(99)00237-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A11,,O=C(O)CN(CCN(CC(=O)O)C(COCc1ccccc1)C(=O)O)CCN(CC(=O)O)C(COCc1ccccc1)C(=O)O,ligand,Gd,"21,72",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/mrm.1910080208,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A12,,CCCOC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)OCCC)CC(=O)O)CC(=O)O,ligand,Gd,"16,03",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00110a019,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A13,,CN(CCN(CCN(C)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"13,12",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1039/B514173G,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A14,,NC(=O)CN(CCN(CCN(CC(N)=O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"14,6",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1097/00004424-199111001-00077,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A15,H3DTPA-BMEA,COCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCOC)CC(=O)O)CC(=O)O,ligand,Gd,"16,84",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/chem.201405967,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A16,H3DTPA-BMA,CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NC)CC(=O)O)CC(=O)O,ligand,Gd,"16,72",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/0730-725X(90)90055-7,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A16,H3DTPA-BMA,CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NC)CC(=O)O)CC(=O)O,ligand,Gd,"16,85",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/mrm.1910080208,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A17,H3DTPA-BPA,CCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCC)CC(=O)O)CC(=O)O,ligand,Gd,"16,23",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1039/B514173G,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A18,,CCCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCCC)CC(=O)O)CC(=O)O,ligand,Gd,"16,5",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.6b02158,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A19,,CCOC(=O)CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCC(=O)OCC)CC(=O)O)CC(=O)O,ligand,Gd,"16,7",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.6b02158,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A20,,O=C(O)CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"16,17",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1097/00004424-199111001-00077,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A21,,COCCN(C)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(C)CCOC)CC(=O)O)CC(=O)O,ligand,Gd,"17,68",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1097/00004424-199111001-00077,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A22,,COCCN(CCO)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(CCO)CCOC)CC(=O)O)CC(=O)O,ligand,Gd,"17,49",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1039/B514173G,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A23,,CCCCN(CCCC)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(CCCC)CCCC)CC(=O)O)CC(=O)O,ligand,Gd,19,3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/0730-725X(90)90055-7,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A24,,O=C(O)CN(CCN(CC(=O)O)Cc1ccccn1)CCN(CC(=O)O)Cc1ccccn1,ligand,Gd,"16,83",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/mrm.1910080208,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A25,,CCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"19,68",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/mrm.1910080208,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A26,,CCCOC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"18,91",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejic.200901261,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A27,H5BOPTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)C(COCc1ccccc1)C(=O)O,ligand,Gd,"21,91",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0277-5387(00)86256-7,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A28,,O=C(O)CCN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"19,74",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1039/b005298l,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A29,,CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"19,4",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0010-8545(99)00237-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A30,,O=C(O)CN(CCN(CCN(CC(=O)O)C(COCc1ccccc1)C(=O)O)C(COCc1ccccc1)C(=O)O)C(COCc1ccccc1)C(=O)O,ligand,Gd,"22,18",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic001117r,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A31,,O=C(O)CN(CCN(CC(=O)O)CC(COP(=O)(O)OC1CCC(c2ccccc2)(c2ccccc2)CC1)N(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"22,06",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic001117r,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A31,,O=C(O)CN(CCN(CC(=O)O)CC(COP(=O)(O)OC1CCC(c2ccccc2)(c2ccccc2)CC1)N(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"23,2",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic981072i,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A32,H5EOB-DTPA,CCOc1ccc(CC(CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)cc1,ligand,Gd,"23,46",3,figure 1,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/chem.200204612,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A33,,O=C(O)CN(CCCN(CC(=O)O)CC(=O)O)CCCN(CC(=O)O)CC(=O)O,ligand,Gd,13,4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/chem.200204612,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A34,,O=C(O)CN(CCCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"17,5",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1039/b506702b,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A35,,CCCCCNC(=O)CN(CCCN(CCN(CC(=O)O)CC(=O)NCCCCC)CC(=O)O)CC(=O)O,ligand,Gd,"13,44",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic5020225,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A36,H4OBETA,O=C(O)CN(CCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"19,37",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/j100808a028,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A36,,O=C(O)CN(CCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"18,21",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00213a019,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A37,,O=C(O)CCN(CCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"15,21",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00178a027,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A38,,O=C(O)CN(CCCOCCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"11,74",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1039/b817343e,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A39,,O=C(O)CN(CC(=O)O)Cc1cccc(CN(CC(=O)O)CC(=O)O)n1,ligand,Gd,"18,6",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic5020225,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A40,H4EGTA,O=C(O)CN(CCOCCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"17,66",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/j100808a028,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A40,H4EGTA,O=C(O)CN(CCOCCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"17,5",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1246/BCSJ.66.3377,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A41,H4BAPTA,O=C(O)CN(CC(=O)O)c1ccccc1OCCOc1ccccc1N(CC(=O)O)CC(=O)O,ligand,Gd,"10,6",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/0223-5234(88)90094-3,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A42,H6TTHA,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"28,4",4,figure 2,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/0048-9697(87)90127-6,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A43,H4EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"17,35",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0277-5387(98)00273-3,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A44,,CC(C)NC(=O)CN(CCN(CC(=O)O)CC(=O)NC(C)C)CC(=O)O,ligand,Gd,"12,79",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0277-5387(98)00273-3,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A45,,CC(C)(C)NC(=O)CN(CCN(CC(=O)O)CC(=O)NC(C)(C)C)CC(=O)O,ligand,Gd,"12,76",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1039/b211060a,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A46,,CCCNC(=O)CN(CCN(CC(=O)O)CC(=O)NCCC)CC(=O)O,ligand,Gd,"10,3",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic9613016,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A47,,O=C(O)CN(CCN(CC(=O)O)Cc1ccccn1)Cc1ccccn1,ligand,Gd,"12,37",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/0048-9697(87)90127-6,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A48,,O=C(O)CNCCNCC(=O)O,ligand,Gd,"8,1",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/0020-1693(94)04012-5,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A49,,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)Cc1ccccc1O,ligand,Gd,"18,89",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic502966m,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A50,H4OCTAPA,O=C(O)CN(CCN(CC(=O)O)Cc1cccc(C(=O)O)n1)Cc1cccc(C(=O)O)n1,ligand,Gd,"20,23",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0021-9673(01)91745-5,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A51,,CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"12,98",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic50181a065,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A52,,O=C(O)CN(CCN(CC(=O)O)C(=O)c1ccccc1)CC(=O)O,ligand,Gd,"12,4",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/0020-1693(94)04398-F,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A53,,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)CC(=O)O,ligand,Gd,"17,54",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1515/znc-1997-7-814,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A54,,O=C(O)CN(CCN(CC(=O)O)Cc1ccccn1)CC(=O)O,ligand,Gd,"15,56",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/00221902(61)80275-3,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A55,,O=C(O)CN(CCO)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"15,22",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/0048-9697(87)90127-6,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A56,H4CDTA,O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"19,6",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1002/chem.201503836,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A57,H4CHXOCTAPA,O=C(O)CN(Cc1cccc(C(=O)O)n1)C1CCCCC1N(CC(=O)O)Cc1cccc(C(=O)O)n1,ligand,Gd,"20,68",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00224a041,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A58,H4TMDTA,O=C(O)CN(CCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"13,76",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00224a041,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A59,,O=C(O)CN(CC(=O)O)CC(O)CN(CC(=O)O)CC(=O)O,ligand,Gd,"13,94",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1246/bcsj.65.1566,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A60,H4PhDTA,O=C(O)CN(CC(=O)O)c1ccccc1N(CC(=O)O)CC(=O)O,ligand,Gd,"13,89",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0010-8545(99)00237-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A61,,COCCN(CC(=O)O)CC(=O)O,ligand,Gd,"7,88",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic50001a010,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A62,H3NTA,O=C(O)CN(CC(=O)O)CC(=O)O,ligand,Gd,"11,54",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic50003a009,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A63,H2IDA,O=C(O)CNCC(=O)O,ligand,Gd,"6,68",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0010-8545(99)00237-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A64,,CN(CC(=O)O)CC(=O)O,ligand,Gd,"6,8",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0010-8545(99)00237-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A64,,CN(CC(=O)O)CC(=O)O,ligand,Gd,"6,68",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic50007a042,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A65,,O=C(O)CN(CCO)CC(=O)O,ligand,Gd,"9,01",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0010-8545(99)00237-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A66,,O=C(O)CN(CC(=O)O)C(=O)c1ccccc1,ligand,Gd,"7,04",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1246/bcsj.62.2296,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A67,,O=C(O)CN(CC(=O)O)Cc1ccccc1O,ligand,Gd,"13,55",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A68,,NCC(=O)O,ligand,Gd,"3,72",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A69,,O=C(O)CN(CC(=O)O)C1CCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"14,73",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A70,,O=C(O)CN(CC(=O)O)C1CCC1N(CC(=O)O)Cc1cccc(C(=O)O)n1,ligand,Gd,"17,41",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A71,,O=C(O)CN(Cc1cccc(C(=O)O)n1)C1CCC1N(CC(=O)O)Cc1cccc(C(=O)O)n1,ligand,Gd,18,5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A72,"TREN-1-Me-3,2-HOPO",Cn1ccc(C(=O)NCCN(CCNC(=O)c2ccn(C)c(=O)c2O)CCNC(=O)c2ccn(C)c(=O)c2O)c(O)c1=O,ligand,Gd,"19,2",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A73,"TREN-6-Me-3,2-HOPO",Cc1cc(C(=O)NCCN(CCNC(=O)c2cc(C)[nH]c(=O)c2O)CCNC(=O)c2cc(C)[nH]c(=O)c2O)c(O)c(=O)[nH]1,ligand,Gd,"20,3",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A74,,Cn1ccc(C(=O)NCCN(CCNC(=O)c2ccc(C(=O)CCCO)c(O)c2O)CCNC(=O)c2ccn(C)c(=O)c2O)c(O)c1=O,ligand,Gd,"24,3",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A75,,CCC(=O)c1ccc(C(=O)NCCN(CCNC(=O)c2ccn(C)c(=O)c2O)CCNC(=O)c2ccn(C)c(=O)c2O)c(O)c1O,ligand,Gd,"24,1",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A76,,Cn1ccc(C(=O)NCCN(CCNC(=O)c2ccn(C)c(=O)c2O)CCN(CC(=O)O)CC(=O)O)c(O)c1=O,ligand,Gd,"14,8",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A77,,Cn1ccc(C(=O)NCCN(CCNC(=O)c2ccccc2O)CCNC(=O)c2ccn(C)c(=O)c2O)c(O)c1=O,ligand,Gd,"17,3",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)81210-4,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,A78,,CNC(=O)c1cccc(C(=O)NCCN(CCNC(=O)c2ccn(C)c(=O)c2O)CCNC(=O)c2ccn(C)c(=O)c2O)c1O,ligand,Gd,"16,5",5,figure 3,1,title,4,table 1
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00253a038,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B1,H4DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"24,7",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic2012827,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B2,H4DOTMA,CC(C(=O)O)N1CCN(C(C)C(=O)O)CCN(C(C)C(=O)O)CCN(C(C)C(=O)O)CC1,ligand,Gd,"23,6",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/mrm.1910220215,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B3,,CC1CN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN1CC(=O)O,ligand,Gd,"26,3",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic0353007,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B4,,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)C(Cc2ccc([N+](=O)[O-])cc2)CN(CC(=O)O)CC1,ligand,Gd,"24,2",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejic.200700354,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B5,DOTAM,NC(=O)CN1CCN(CC(N)=O)CCN(CC(N)=O)CCN(CC(N)=O)CC1,ligand,Gd,"13,12",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejic.200700354,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B6,DTMA,CNC(=O)CN1CCN(CC(=O)NC)CCN(CC(=O)NC)CCN(CC(=O)NC)CC1,ligand,Gd,"13,54",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejic.200700354,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B7,DOTAM-Gly,O=C(O)CNC(=O)CN1CCN(CC(=O)NCC(=O)O)CCN(CC(=O)NCC(=O)O)CCN(CC(=O)NCC(=O)O)CC1,ligand,Gd,"14,54",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejic.200700354,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B8,,CCNC(=O)CN1CCN(CC(=O)NCC)CCN(CC(=O)NCC)CCN(CC(=O)NCC)CC1,ligand,Gd,"14,83",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic9600590,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B9,H8DOTP,O=P(O)(O)CN1CCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CC1,ligand,Gd,"28,8",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00026a030,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B10,H4DOPTEt,CCP(=O)(O)CN1CCN(CP(=O)(O)CC)CCN(CP(=O)(O)CC)CCN(CP(=O)(O)CC)CC1,ligand,Gd,"16,5",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejic.200800859,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B11,H4DOTPMeOH,O=P(O)(CO)CN1CCN(CP(=O)(O)CO)CCN(CP(=O)(O)CO)CCN(CP(=O)(O)CO)CC1,ligand,Gd,"16,09",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejic.200800859,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B12,H4DOTPOEt,CCOP(=O)(O)CN1CCN(CP(=O)(O)OCC)CCN(CP(=O)(O)OCC)CCN(CP(=O)(O)OCC)CC1,ligand,Gd,"14,4",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/1099-0682(200103)2001:3<813::aid-ejic813>3.0.co;2-6,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B13,H4DOTPOBu,CCCCOP(=O)(O)CN1CCN(CP(=O)(O)OCCCC)CCN(CP(=O)(O)OCCCC)CCN(CP(=O)(O)OCCCC)CC1,ligand,Gd,"12,19",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic4025958,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B14,H3DO3A,O=C(O)CN1CCNCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"21,56",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.8b00473,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B14,,O=C(O)CN1CCNCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"19,06",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic2001915,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B15,,O=C(O)CN1CCN(CC(=O)O)CCN(Cc2cccc(C(=O)O)n2)CCN(CC(=O)O)CC1,ligand,Gd,"23,31",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/C4DT03939D,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B16,,NCCNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"22,25",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00302a049,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B17,,CCCNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"20,1",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00032a035,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B18,,O=C(O)CN1CCN(CC(=O)O)CCN(C(COCc2ccccc2)C(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"25,93",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00095a028,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B19,H3HE-DO3A,O=C(O)CN1CCN(CCO)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"22,3",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00095a028,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B20,H3HP-DO3A,CC(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"23,8",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00095a028,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B21,H3HIP-DO3A,CC(CO)N1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"23,9",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1135/cccc20051909,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B22,H5DO3AP,O=C(O)CN1CCN(CC(=O)O)CCN(CP(=O)(O)O)CCN(CC(=O)O)CC1,ligand,Gd,"27,5",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.9b00267,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B23,,O=C(O)CN1CCN(CC(=O)O)CCN(CP(=O)(O)CN(Cc2ccccc2)Cc2ccccc2)CCN(CC(=O)O)CC1,ligand,Gd,"23,77",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic961131x,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B24,H2DO2A,O=C(O)CN1CCNCCN(CC(=O)O)CCNCC1,ligand,Gd,"19,1",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic7024704,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B25,H6DO2A2P,O=C(O)CN1CCN(CP(=O)(O)O)CCN(CC(=O)O)CCN(CP(=O)(O)O)CC1,ligand,Gd,"25,7",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic961131x,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B26,H2HE2-DO2A,O=C(O)CN1CCN(CCO)CCN(CC(=O)O)CCN(CCO)CC1,ligand,Gd,"21,1",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic961131x,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B27,H2HP2-DO2A,CC(O)CN1CCN(CC(=O)O)CCN(CC(C)O)CCN(CC(=O)O)CC1,ligand,Gd,"22,5",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/C4DT02985B,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B28,,O=C(O)c1cccc(CN2CCNCCN(Cc3cccc(C(=O)O)n3)CCNCC2)n1,ligand,Gd,"17,27",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/C4DT02985B,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B29,,CN1CCN(Cc2cccc(C(=O)O)n2)CCN(C)CCN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"17,59",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.0c00520,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B30,,CN1CCN(CC(=O)O)CCN(Cc2cccc(C(=O)O)n2)CCN(CC(=O)O)CC1,ligand,Gd,"16,69",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.0c00520,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B31,,CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"17,12",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/a909098c,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B32,,O=C(O)C(CO)N1CCNCCN(C(CO)C(=O)O)CCN(C(CO)C(=O)O)CC1,ligand,Gd,"18,82",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/a909098c,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B33,,CC(O)CN1CCN(CC(C)O)CCN(C(CO)C(=O)O)CCN(CC(C)O)CC1,ligand,Gd,"19,4",5,figure 4,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic0608750,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B34,H3PCTA,O=C(O)CN1CCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CC1,ligand,Gd,"20,39",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/chem.201705528,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B34,H3PCTA,O=C(O)CN1CCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CC1,ligand,Gd,"18,28",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/bc8004914,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B35,,O=C(O)CN1CCN(CC(=O)O)CC(Cc2ccc([N+](=O)[O-])cc2)N(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,"19,42",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00112a040,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B36,H2PC2A,O=C(O)CN1CCNCCN(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,"16,6",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/chem.201705528,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B37,,O=C(O)CN1CCN(CC(=O)O)Cc2cccc(n2)CN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"22,37",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/chem.201705528,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B38,,O=C(O)CN1CCN(Cc2cccc(C(=O)O)n2)CCN(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,"20,49",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.8b00598,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B39,,O=C(O)CN1CCN(Cc2cccc(C(=O)O)n2)CCN(Cc2cccc(C(=O)O)n2)Cc2cccc(n2)C1,ligand,Gd,"23,44",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.8b00598,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B40,,O=C(O)CN1CCN(Cc2cccc(C(=O)O)n2)Cc2cccc(n2)CN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"23,56",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00112a040,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B41,,O=C(O)CN1Cc2cccc(n2)CN(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,"14,5",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic301369z,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B42,,O=C(O)c1cccc(CN2Cc3cccc(n3)CN(Cc3cccc(C(=O)O)n3)Cc3cccc(n3)C2)n1,ligand,Gd,"13,62",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejoc.200400264,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B43,,O=C(O)CN1CCCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CCC1,ligand,Gd,"9,34",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)80229-7,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B44,H4TRITA,O=C(O)CN1CCCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"19,17",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1016/S0020-1693(00)80229-7,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B45,H4TETA,O=C(O)CN1CCCN(CC(=O)O)CCN(CC(=O)O)CCCN(CC(=O)O)CC1,ligand,Gd,"13,77",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic9011197,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B46,,O=C(O)c1cccc(CN2CCOCCN(Cc3cccc(C(=O)O)n3)CCOCC2)n1,ligand,Gd,"18,82",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00067a022,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,B47,H3ODOTRA,O=C(O)CN1CCOCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"21,6",7,figure 5,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00009a027,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,C1,H3NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"13,7",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/ejic.201101162,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,C2,,O=C(O)CN1CCN(CC(=O)O)CCN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"13,9",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1002/chem.200501390,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,C3,,O=C(O)CN1CCN(Cc2cccc(C(=O)O)n2)CCN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"15,8",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/b907738c,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,C4,,O=C(O)CCN1CCN(Cc2cccc(C(=O)O)n2)CCN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"15,1",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/b907738c,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,C5,,O=C(O)c1cccc(CN2CCN(Cc3cccc(C(=O)O)n3)CCN(CP(=O)(O)O)CC2)n1,ligand,Gd,"19,5",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00168a010,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,D1,H2DACDA,O=C(O)CN1CCOCCOCCN(CC(=O)O)CCOCCOCC1,ligand,Gd,"11,93",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ja808534w,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,D2,H2MACROPA,O=C(O)c1cccc(CN2CCOCCOCCN(Cc3cccc(C(=O)O)n3)CCOCCOCC2)n1,ligand,Gd,"13,02",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00294a023,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,D3,,O=C(O)CCN1CCOCCOCCN(CCC(=O)O)CCOCCOCC1,ligand,Gd,"7,02",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00294a023,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,D4,,O=C(O)CN1CCOCCOCCNCCOCCOCC1,ligand,Gd,"7,29",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00067a022,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,D5,,O=C(O)CN1CCOCCN(CC(=O)O)CCOCCN(CC(=O)O)CCOCC1,ligand,Gd,"18,02",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1080/10610279608032556,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,D6,H4PYTA,O=C(O)CN1CCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CCN(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,"21,7",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00223a025,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,E1,,O=C(O)CN1CCOCCOCCN(CC(=O)O)CCOCC1,ligand,Gd,"11,66",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/C0DT00746C,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,E2,,O=C(O)c1cccc(CN2CCOCCOCCN(Cc3cccc(C(=O)O)n3)CCOCC2)n1,ligand,Gd,"11,41",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00067a022,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,E3,,O=C(O)CN1CCOCCN(CC(=O)O)CCN(CC(=O)O)CCOCC1,ligand,Gd,"17,23",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1006/mchj.1996.0026,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,E4,,O=C(O)CCN1CCOCCN(CCC(=O)O)CCN(CCC(=O)O)CCOCC1,ligand,Gd,"11,23",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/C0DT00746C,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,F1,H4AAZTA,O=C(O)CC(CC(=O)O)C1CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Gd,"20,24",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00067a023,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,F1,H4AAZTA,O=C(O)CN1CCN(CC(=O)O)CC(N(CC(=O)O)CC(=O)O)C1,ligand,Gd,"18,93",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1006/mchj.1996.0027,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,F2,,O=C(O)CCCCC1(N(CC(=O)O)CC(=O)O)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Gd,"20,33",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/C0DT00746C,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,F3,,O=C(O)CCC1(N(CC(=O)O)CC(=O)O)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Gd,"20,06",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1021/ic00067a024,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,F4,,CC1(C(CC(=O)O)CC(=O)O)CN(CC(=O)O)C2CCCCC2N(CC(=O)O)C1,ligand,Gd,"18,26",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1006/mchj.1996.0028,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,F5,,CC1(C(CC(=O)O)Cc2ccccc2O)CN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Gd,"25,06",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1039/C0DT00746C,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,F6,,CC1(N(CC(=O)O)CC(=O)O)CN(CC(=O)O)CCN(Cc2ccccc2O)C1,ligand,Gd,"19,57",8,figure 6,1,title,6,table 2
uzal2022,10.1016/j.ccr.2022.214606,10.1016/j.ccr.2022.214606,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T1,,O=C(O)CN1CCN(CC(=O)O)CCN(Cc2ccccn2)CC1,ligand,Gd,"12,55",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1016/j.ccr.2022.214606,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T2,,NC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"11,9",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1016/j.ccr.2022.214606,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T3,,O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)Cc1ccccn1,ligand,Gd,"14,47",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1016/j.ccr.2022.214606,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T4,,O=C(O)CN(Cc1ccccn1)C1CCCCC1N(CC(=O)O)Cc1ccccn1,ligand,Gd,"12,07",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1016/j.ccr.2022.214606,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T5,,O=C(O)CN(Cc1cccc(C(=O)O)n1)Cc1cccc(C(=O)O)n1,ligand,Gd,"16,2",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1016/j.ccr.2022.214606,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T6,,O=C(O)c1cccc(CN(Cc2cccc(C(=O)O)n2)Cc2cccc(C(=O)O)n2)n1,ligand,Gd,"17,77",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.0c00372,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T7,,CN(CCOCCN(C)Cc1cccc(C(=O)O)n1)Cc1cccc(C(=O)O)n1,ligand,Gd,"12,02",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.0c00372,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T8,,O=C(O)CN(CCOCCN(CC(=O)O)Cc1cccc(C(=O)O)n1)Cc1cccc(C(=O)O)n1,ligand,Gd,"20,5",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.3390/molecules24183324,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T9,,O=P(O)(O)CN1CCNCCNCCN(CP(=O)(O)O)CC1,ligand,Gd,"19,15",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.1c01927,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T10,,O=C(O)CN1CCN(CC(=O)O)CCN(CC(O)C(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"19,26",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1021/acs.inorgchem.9b03345,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T11,,O=C(O)CN1Cc2cccc(n2)CN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,"18,3",13,figure 12,1,title,14,table 4
uzal2022,10.1016/j.ccr.2022.214606,10.1039/C7DT04104G,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T12,,CCCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"18,78",13,figure 12,1,title,14,table 4
uzal2023,10.1016/j.ccr.2022.214606,10.1039/C7DT04104G,0,Prediction of Gd(III) complex thermodynamic stability,Elsevier BV,2022,1,T13,,CCCCNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)NCCCC)CCN(CC(=O)O)CC1,ligand,Gd,"19,3",13,figure 12,1,title,14,table 4
dioury2014,10.1021/ci500346w,10.1002/ejoc.200400264,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,1,PCTA14,O=C(O)CN1CCCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CCC1,ligand,Gd,"9,34",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic960794b,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,1,PCTA14,O=C(O)CN1CCCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CCC1,ligand,Gd,"12,5",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic960794b,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,2,PCTA13,O=C(O)CN1CCCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CC1,ligand,Gd,"19,3",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic0608750,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,3,PCTA12,O=C(O)CN1CCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CC1,ligand,Gd,"20,39",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic960794b,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,3,PCTA12,O=C(O)CN1CCN(CC(=O)O)Cc2cccc(n2)CN(CC(=O)O)CC1,ligand,Gd,21,31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/bc8004914,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,4,NB-PCTA12,O=C(O)CN1CCN(CC(=O)O)CC(Cc2ccc([N+](=O)[O-])cc2)N(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,"19,42",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00112a040,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,5,BP2A,O=C(O)CN1Cc2cccc(n2)CN(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,"14,5",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00112a040,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,6,PC2A,O=C(O)CN1CCNCCN(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,"16,6",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00091a032,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,7,DTPA-OAM,O=C(O)CN1CCN(CC(=O)O)CC(=O)NCCOCCOCCNC(=O)CN(CC(=O)O)CC1,ligand,Gd,"17,4",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00046a015,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,7,DTPA-OAM,O=C(O)CN1CCN(CC(=O)O)CC(=O)NCCOCCOCCNC(=O)CN(CC(=O)O)CC1,ligand,Gd,"17,44",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00046a015,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,8,DTPA-XAM,O=C(O)CN1CCN(CC(=O)O)CC(=O)NCc2ccc(cc2)CNC(=O)CN(CC(=O)O)CC1,ligand,Gd,"12,34",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00046a015,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,9,DTPA-PenAM,O=C(O)CN1CCN(CC(=O)O)CC(=O)NCCCCCNC(=O)CN(CC(=O)O)CC1,ligand,Gd,"15,94",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00067a022,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,10,TTCT,O=C(O)CN1CCOCCN(CC(=O)O)CCOCCN(CC(=O)O)CCOCC1,ligand,Gd,"18,02",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1016/0730-725x(92)90444-5,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,10,TTCT,O=C(O)CN1CCOCCN(CC(=O)O)CCOCCN(CC(=O)O)CCOCC1,ligand,Gd,"18,07",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1002/chin.198201094,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,11,TTCT-Me3,CC(C(=O)O)N1CCOCCN(C(C)C(=O)O)CCOCCN(C(C)C(=O)O)CCOCC1,ligand,Gd,"16,27",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00168a010,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,12,DACDA,O=C(O)CN1CCOCCOCCN(CC(=O)O)CCOCCOCC1,ligand,Gd,"11,93",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00046a015,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,13,DTPA-BAM,O=C(O)CN1CCN(CC(=O)O)CC(=O)NCCCCNC(=O)CN(CC(=O)O)CC1,ligand,Gd,"15,39",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00046a015,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,14,DTPA-cisC=C-BAM,O=C(O)CN1CCN(CC(=O)O)CC(=O)NCC=CCNC(=O)CN(CC(=O)O)CC1,ligand,Gd,"15,56",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00046a015,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,15,DTPA-PAM,O=C(O)CN1CCN(CC(=O)O)CC(=O)NCCCNC(=O)CN(CC(=O)O)CC1,ligand,Gd,"14,49",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00046a015,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,16,EDTA-DAM,O=C(O)CN1CCNC(=O)CN(CC(=O)O)CCN(CC(=O)O)CC(=O)NCC1,ligand,Gd,"15,14",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00091a032,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,16,EDTA-DAM,O=C(O)CN1CCNC(=O)CN(CC(=O)O)CCN(CC(=O)O)CC(=O)NCC1,ligand,Gd,"15,3",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00067a022,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,17,N-ac3[15]aneN3O2,O=C(O)CN1CCOCCN(CC(=O)O)CCN(CC(=O)O)CCOCC1,ligand,Gd,"17,23",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(97)05660-0,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,17,N-ac3[15]aneN3O2,O=C(O)CN1CCOCCN(CC(=O)O)CCN(CC(=O)O)CCOCC1,ligand,Gd,"17,3",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1006/mchj.1996.0026,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,18,N-ac3[15]aneN3O2-Me3,CC(C(=O)O)N1CCOCCN(C(C)C(=O)O)CCN(C(C)C(=O)O)CCOCC1,ligand,Gd,"11,49",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00223a025,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,19,DAPDA,O=C(O)CN1CCOCCOCCN(CC(=O)O)CCOCC1,ligand,Gd,"11,66",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(00)80229-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,20,TETA,O=C(O)CN1CCCN(CC(=O)O)CCN(CC(=O)O)CCCN(CC(=O)O)CC1,ligand,Gd,"13,77",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00006a021,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,20,TETA,O=C(O)CN1CCCN(CC(=O)O)CCN(CC(=O)O)CCCN(CC(=O)O)CC1,ligand,Gd,"14,73",31,table S5,1,title,2,table S1
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(00)80229-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,21,TRITA,O=C(O)CN1CCCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"19,17",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00032a034,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"22,1",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1016/0020-1693(94)03964-x,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"23,6",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(00)80229-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,24,31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00253a038,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"24,6",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1016/0020-1693(96)05182-1,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"24,67",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1351/pac200577081445,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,25,31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00094a021,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"25,3",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1002/mrm.1910220215,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"25,6",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1039/a700519i,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"26,03",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00032a035,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,27,31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.3406/barb.1978.58463,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,22,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,28,31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1002/mrm.1910220215,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,23,MCTA,CC1CN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN1CC(=O)O,ligand,Gd,"26,3",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic0353007,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,24,NB-DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)C(Cc2ccc([N+](=O)[O-])cc2)CN(CC(=O)O)CC1,ligand,Gd,"24,2",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00032a035,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,25,DOTA-BOM1,O=C(O)CN1CCN(CC(=O)O)CCN(C(COCc2ccccc2)C(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"25,93",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00032a035,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,26,DOTA-BOM2c,O=C(O)CN1CCN(CC(=O)O)CCN(C(COCc2ccccc2)C(=O)O)CCN(C(COCc2ccccc2)C(=O)O)CC1,ligand,Gd,"25,95",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1016/s0010-8545(99)00237-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,27,DOTMA,CC(C(=O)O)N1CCN(C(C)C(=O)O)CCN(C(C)C(=O)O)CCN(C(C)C(=O)O)CC1,ligand,Gd,"23,6",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic2012843,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,28,NB-DOTMA-1,CC(C(=O)O)N1CCN(CC(=O)O)C(Cc2ccc([N+](=O)[O-])cc2)CN(C(C)C(=O)O)CCN(C(C)C(=O)O)CC1,ligand,Gd,"21,53",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic2012843,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,29,NB-DOTMA,CC(C(=O)O)N1CCN(C(C)C(=O)O)CCN(C(C)C(=O)O)C(Cc2ccc([N+](=O)[O-])cc2)CN(C(C)C(=O)O)CC1,ligand,Gd,"23,86",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1002/ejic.200300085,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,30,P730,O=C(O)CCC(C(=O)O)N1CCN(C(CCC(=O)O)C(=O)O)CCN(C(CCC(=O)O)C(=O)O)CCN(C(CCC(=O)O)C(=O)O)CC1,ligand,Gd,"24,03",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00302a049,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,31,DOTA-PA,CCCNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"20,1",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ci500346w,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,32,AP-DO3A,CNCC(=O)N1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"21,54",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00095a028,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,33,HE-DO3A,O=C(O)CN1CCN(CCO)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"22,3",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00094a021,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,34,HP-DO3A,CC(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"23,8",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1039/a909098c,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,34,HP-DO3A,CC(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"24,5",31,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00095a028,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,35,HIP-DO3A,CC(CO)N1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"23,9",32,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1016/0020-1693(96)05094-3,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,36,trans-DO3A-Bu,O=C(O)CN1CCN(CC(=O)O)CCN(C(CO)C(O)CO)CCN(CC(=O)O)CC1,ligand,Gd,"18,7",32,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1016/0020-1693(96)05094-3,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,36,trans-DO3A-Bu,O=C(O)CN1CCN(CC(=O)O)CCN(C(CO)C(O)CO)CCN(CC(=O)O)CC1,ligand,Gd,"20,8",32,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1016/0020-1693(96)05094-3,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,36,trans-DO3A-Bu,O=C(O)CN1CCN(CC(=O)O)CCN(C(CO)C(O)CO)CCN(CC(=O)O)CC1,ligand,Gd,"21,8",32,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1039/a909098c,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,37,HPDO3A-3HM,CC(O)CN1CCN(C(CO)C(=O)O)CCN(C(CO)C(=O)O)CCN(C(CO)C(=O)O)CC1,ligand,Gd,"19,4",32,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1016/s0010-8545(99)00237-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,38,HPDO3A-3BHM,CC(O)CN1CCN(C(COCc2ccccc2)C(=O)O)CCN(C(COCc2ccccc2)C(=O)O)CCN(C(COCc2ccccc2)C(=O)O)CC1,ligand,Gd,"18,37",32,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00067a022,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,39,ODOTRA,O=C(O)CN1CCOCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"21,6",32,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00094a021,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,40,DO3A,O=C(O)CN1CCNCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,21,32,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1351/pac200577081445,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,40,DO3A,O=C(O)CN1CCNCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"22,02",32,table S5,1,title,3,table S1
dioury2014,10.1021/ci500346w,10.1039/a909098c,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,41,DO3A-3HM,O=C(O)C(CO)N1CCNCCN(C(CO)C(=O)O)CCN(C(CO)C(=O)O)CC1,ligand,Gd,"18,82",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1016/s0010-8545(99)00237-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,42,DO3A-3BHM,O=C(O)C(COCc1ccccc1)N1CCNCCN(C(COCc2ccccc2)C(=O)O)CCN(C(COCc2ccccc2)C(=O)O)CC1,ligand,Gd,"18,21",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1021/ic961131x,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,43,DO2A-2HE,O=C(O)CN1CCN(CCO)CCN(CC(=O)O)CCN(CCO)CC1,ligand,Gd,"21,1",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1021/ic961131x,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,44,DO2A-2HP,CC(O)CN1CCN(CC(=O)O)CCN(CC(C)O)CCN(CC(=O)O)CC1,ligand,Gd,"22,5",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1021/ja00130a008,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,45,DOTAM,NC(=O)CN1CCN(CC(N)=O)CCN(CC(N)=O)CCN(CC(N)=O)CC1,ligand,Gd,"10,05",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1002/ejic.200700354,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,45,DOTAM,NC(=O)CN1CCN(CC(N)=O)CCN(CC(N)=O)CCN(CC(N)=O)CC1,ligand,Gd,"13,12",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1039/a909098c,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,46,DTMA,CNC(=O)CN1CCN(CC(=O)NC)CCN(CC(=O)NC)CCN(CC(=O)NC)CC1,ligand,Gd,"12,8",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1002/ejic.200700354,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,46,DTMA,CNC(=O)CN1CCN(CC(=O)NC)CCN(CC(=O)NC)CCN(CC(=O)NC)CC1,ligand,Gd,"13,54",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1002/ejic.200700354,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,47,DOTA-(EtAm)4,CCNC(=O)CN1CCN(CC(=O)NCC)CCN(CC(=O)NCC)CCN(CC(=O)NCC)CC1,ligand,Gd,"14,83",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1002/hlca.200590042,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,48,DOTA-(Gly)4,O=C(O)CNC(=O)CN1CCN(CC(=O)NCC(=O)O)CCN(CC(=O)NCC(=O)O)CCN(CC(=O)NCC(=O)O)CC1,ligand,Gd,"14,54",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00009a027,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,49,DETA,O=C(O)CN1CCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"15,1",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00009a027,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,50,MeDETA,CC1CN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Gd,"14,7",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00009a027,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,51,Me2DETA,CC1(C)CN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)C1,ligand,Gd,"10,4",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00009a027,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,52,NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"13,7",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1021/ic00253a038,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,52,NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"14,3",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1524/ract.1993.61.34.207,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,53,NOTMA,CC(C(=O)O)N1CCN(C(C)C(=O)O)CCN(C(C)C(=O)O)CC1,ligand,Gd,"12,8",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1002/ejic.201101162,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,54,mpatcn,O=C(O)CN1CCN(CC(=O)O)CCN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"13,9",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1002/chem.200501390,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,55,bpatcn,O=C(O)CN1CCN(Cc2cccc(C(=O)O)n2)CCN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"15,8",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1039/b907738c,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,56,ebpatcn,O=C(O)CCN1CCN(Cc2cccc(C(=O)O)n2)CCN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,"15,1",32,table S5,1,title,4,table S1
dioury2014,10.1021/ci500346w,10.1016/s0010-8545(00)80110-1,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,57,TPHA,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"20,41",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/0022-1902(81)80122-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,57,TPHA,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"20,42",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/s0010-8545(99)00237-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,58,CE-DTPA,O=C(O)CCC(C(=O)O)N(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"21,66",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1515/znc-1997-7-814,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,59,TTAHA,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,19,32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/0022-1902(77)80538-1,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"20,73",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1002/ejic.200901261,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,03",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00094a021,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,2",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1002/mrm.1910080208,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,26",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00253a038,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,3",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic991189m,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,46",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/0022-1902(62)80236-x,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,46",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic981072i,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,52",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1002/mrm.1910220215,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,9",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/0022-1902(59)80246-3,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,60,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"23,01",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1002/ejic.200901261,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,61,BOPTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)C(COCc1ccccc1)C(=O)O,ligand,Gd,"21,91",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/s0010-8545(99)00237-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,61,BOPTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)C(COCc1ccccc1)C(=O)O,ligand,Gd,"22,58",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00107a017,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,61,BOPTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)C(COCc1ccccc1)C(=O)O,ligand,Gd,"22,59",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/jm9602118,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,62,LDTPA,Nc1ccc(CC(C(=O)O)N(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O)cc1,ligand,Gd,"21,99",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/s0010-8545(99)00237-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,63,EOB-DTPA,CCOc1ccc(CC(CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)cc1,ligand,Gd,"22,76",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic981072i,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,63,EOB-DTPA,CCOc1ccc(CC(CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)cc1,ligand,Gd,"23,46",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1002/chem.200204612,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,64,EPTPA-bz-NO2,O=C(O)CN(CCCN(CC(=O)O)CC(Cc1ccc([N+](=O)[O-])cc1)N(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"19,2",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic991189m,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,65,cycy(m)DTPA,O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"20,71",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic991189m,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,65,cycy(m)DTPA,O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"20,42",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/s0277-5387(00)86256-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,66,DTTAP,O=C(O)CCN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"19,74",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1002/chem.200204612,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,67,DPTPA,O=C(O)CN(CCCN(CC(=O)O)CC(=O)O)CCCN(CC(=O)O)CC(=O)O,ligand,Gd,13,32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/s0277-5387(00)00502-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,68,DTPA-PY,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)Cc1ccccn1)CC(=O)O,ligand,Gd,"21,59",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1016/s0277-5387(00)00502-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,69,DTPA-HP,CC(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"18,48",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1039/b005298l,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,70,DTPA-N'-MA,CNC(=O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"19,9",32,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1039/b005298l,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,71,DTPA-N-MA,CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"19,3",33,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1002/mrm.1910080208,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,72,DTPA-PA,CCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"19,68",33,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1002/mrm.1910080208,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,73,DTPA-PE,CCCOC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"18,91",33,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00212a005,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,74,DEATA,CCN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"17,79",33,table S5,1,title,11,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00212a005,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,75,BEATA,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)c1ccccc1)CC(=O)O,ligand,Gd,"15,42",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/b107456n,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,76,TTDA-HP,CC(O)CN(CCCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"17,33",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/b107456n,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,77,TTDA-H1P,O=C(O)CN(CCCN(CCN(CC(=O)O)CC(=O)O)C(CO)c1ccccc1)CC(=O)O,ligand,Gd,"17,16",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/b107456n,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,78,TTDA-H2P,O=C(O)CN(CCCN(CCN(CC(=O)O)CC(=O)O)CC(O)c1ccccc1)CC(=O)O,ligand,Gd,"17,44",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1002/mrm.1910080208,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,79,DTPA-PE2,CCCOC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)OCCC)CC(=O)O)CC(=O)O,ligand,Gd,"16,3",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/b514173g,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,80,DTPA-BA,NC(=O)CN(CCN(CCN(CC(N)=O)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"14,6",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1002/ejic.200901261,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,81,DTPA-BMA,CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NC)CC(=O)O)CC(=O)O,ligand,Gd,"16,64",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/0730-725x(90)90055-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,81,DTPA-BMA,CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NC)CC(=O)O)CC(=O)O,ligand,Gd,"16,85",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1002/mrm.1910080208,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,82,DTPA-PA2,CCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCC)CC(=O)O)CC(=O)O,ligand,Gd,"16,23",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/a605483h,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,83,DTPA-BiPA,CC(C)NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NC(C)C)CC(=O)O)CC(=O)O,ligand,Gd,"17,07",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1097/00004424-199009001-00026,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,84,DTPA-BnBA,CCCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCCC)CC(=O)O)CC(=O)O,ligand,Gd,"15,9",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/b514173g,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,84,DTPA-BnBA,CCCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCCC)CC(=O)O)CC(=O)O,ligand,Gd,"16,5",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/a605483h,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,85,DTPA-BtBA,CC(C)(C)NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NC(C)(C)C)CC(=O)O)CC(=O)O,ligand,Gd,"17,15",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/a605483h,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,86,DTPA-BBA,O=C(O)CN(CCN(CC(=O)O)CC(=O)NCc1ccccc1)CCN(CC(=O)O)CC(=O)NCc1ccccc1,ligand,Gd,"16,48",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/s0277-5387(97)00476-2,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,87,DTPA-BAdA,O=C(O)CN(CCN(CC(=O)O)CC(=O)NC12CC3CC(CC(C3)C1)C2)CCN(CC(=O)O)CC(=O)NC12CC3CC(CC(C3)C1)C2,ligand,Gd,"16,85",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1097/00004424-199009001-00026,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,88,DTPA-BMEA,COCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCOC)CC(=O)O)CC(=O)O,ligand,Gd,"16,48",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(96)05522-3,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,88,DTPA-BMEA,COCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCOC)CC(=O)O)CC(=O)O,ligand,Gd,"16,84",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/s0277-5387(97)00476-2,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,89,DTPA-BMBA,COc1ccccc1CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCc1ccccc1OC)CC(=O)O)CC(=O)O,ligand,Gd,"16,82",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/s0277-5387(97)00476-2,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,90,DTPA-BMPEA,COc1ccccc1CCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCc1ccccc1OC)CC(=O)O)CC(=O)O,ligand,Gd,"16,91",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1097/00004424-199111001-00074,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,91,DTPA-BDA,O=C(O)CN(CCN(CC(=O)O)CC(=O)NCCN(CCO)CCO)CCN(CC(=O)O)CC(=O)NCCN(CCO)CCO,ligand,Gd,"16,7",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/b514173g,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,92,DTPA-B(BbuA),CCCCN(CCCC)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(CCCC)CCCC)CC(=O)O)CC(=O)O,ligand,Gd,19,33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1097/00004424-199111001-00077,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,93,DTPA-BMMEA,COCCN(C)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(C)CCOC)CC(=O)O)CC(=O)O,ligand,Gd,"17,68",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(96)05522-3,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,93,DTPA-BMMEA,COCCN(C)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(C)CCOC)CC(=O)O)CC(=O)O,ligand,Gd,"17,69",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1097/00004424-199111001-00074,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,94,DTPA-BMAMEA,COCCNC(=O)CN(C)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(C)CC(=O)NCCOC)CC(=O)O)CC(=O)O,ligand,Gd,"17,1",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1097/00004424-199111001-00074,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,95,DTPA-BDMEA,COCCN(CCOC)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(CCOC)CCOC)CC(=O)O)CC(=O)O,ligand,Gd,"19,2",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(96)05522-3,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,96,DTPA-BHMEA,COCCN(CCO)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(CCO)CCOC)CC(=O)O)CC(=O)O,ligand,Gd,"17,49",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/0730-725x(90)90055-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,97,DTPA-BP,O=C(O)CN(CCN(CC(=O)O)Cc1ccccn1)CCN(CC(=O)O)Cc1ccccn1,ligand,Gd,"16,83",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/0730-725x(92)90444-5,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,98,DTTA-HP,Cc1ccc(O)c(CN(CCN(CCN(CC(=O)O)Cc2nc(C)ccc2O)CC(=O)O)CC(=O)O)n1,ligand,Gd,"23,65",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00110a019,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,99,DTTA-BM,CN(CCN(CCN(C)CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"13,12",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1039/b417272h,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,100,DTPA-TrA,CCCCN(CCCC)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(CCCC)CCCC)CC(=O)NC)CC(=O)O,ligand,Gd,"17,93",33,table S5,1,title,12,table S2
dioury2014,10.1021/ci500346w,10.1016/0022-1902(77)80538-1,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,101,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"16,28",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1021/ja01113a020,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,101,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"16,7",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/s0010-8545(99)00237-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,101,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"17,35",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1002/hlca.19540370402,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,101,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"17,37",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1002/chin.198535056,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,101,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"17,4",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1135/cccc19781450,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,101,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"17,53",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00094a021,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,101,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"17,7",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1135/cccc19781450,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,102,PDTA,CC(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Gd,"18,15",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/0022-1902(64)80019-1,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,102,PDTA,CC(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Gd,"18,21",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/s0003-2670(01)95804-0,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,102,PDTA,CC(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Gd,"18,87",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1135/cccc19781450,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,103,MePDTA,CC(C)(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Gd,"17,09",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/s0003-2670(01)95804-0,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,104,"trans-1,2-CPDTA",O=C(O)CN(CC(=O)O)C1CCCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"18,24",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/0022-1902(77)80538-1,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,105,"trans-1,2-CDTA",O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"18,12",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1002/hlca.19540370402,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,105,"trans-1,2-CDTA",O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"18,77",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/0022-1902(62)80018-9,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,105,"trans-1,2-CDTA",O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"18,8",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/s0003-2670(00)84867-9,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,105,"trans-1,2-CDTA",O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"18,97",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1002/chin.198535056,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,105,"trans-1,2-CDTA",O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Gd,"19,5",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1002/hlca.19640470715,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,106,TMTA,O=C(O)CN(CCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"13,74",33,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1002/ejic.201101294,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,107,DMPDTA,CC(C)(CN(CC(=O)O)CC(=O)O)CN(CC(=O)O)CC(=O)O,ligand,Gd,"12,3",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00224a041,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,108,DHPTA,O=C(O)CN(CC(=O)O)CC(O)CN(CC(=O)O)CC(=O)O,ligand,Gd,"13,94",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/s0277-5387(00)87165-x,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,109,PMDTA,O=C(O)CN(CCCCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"10,37",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00178a027,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,110,BPETA,O=C(O)CN(CCCOCCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"11,74",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1021/j100808a028,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,111,EGTA,O=C(O)CN(CCOCCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"16,94",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1021/j100808a028,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,111,EGTA,O=C(O)CN(CCOCCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"17,5",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1246/bcsj.66.3377,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,112,BAPTA,O=C(O)CN(CC(=O)O)c1ccccc1OCCOc1ccccc1N(CC(=O)O)CC(=O)O,ligand,Gd,"10,6",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1002/jccs.199000033,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,112,BAPTA,O=C(O)CN(CC(=O)O)c1ccccc1OCCOc1ccccc1N(CC(=O)O)CC(=O)O,ligand,Gd,"10,94",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00213a019,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,113,DETAP,O=C(O)CCN(CCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"15,21",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1039/b416150e,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,114,bpeda,O=C(O)CN(CCN(CC(=O)O)Cc1cccc(C(=O)O)n1)Cc1cccc(C(=O)O)n1,ligand,Gd,"15,1",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00234a009,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,115,MEDTA,CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"12,98",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1021/ic50181a065,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,116,BEDTA,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1)CC(=O)O,ligand,Gd,"12,4",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/s0010-8545(99)00237-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,116,BEDTA,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1)CC(=O)O,ligand,Gd,"12,58",34,table S5,1,title,13,table S2
dioury2014,10.1021/ci500346w,10.1016/0020-1693(94)04398-f,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,117,HBET,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)CC(=O)O,ligand,Gd,"17,54",34,table S5,1,title,14,table S2
dioury2014,10.1021/ci500346w,10.1515/znc-1997-7-814,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,118,PEDTA,O=C(O)CN(CCN(CC(=O)O)Cc1ccccn1)CC(=O)O,ligand,Gd,"15,56",34,table S5,1,title,14,table S2
dioury2014,10.1021/ci500346w,10.1016/0022-1902(77)80538-1,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,119,HEDTA,O=C(O)CN(CCO)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"14,8",34,table S5,1,title,14,table S2
dioury2014,10.1021/ci500346w,10.1021/ja01582a007,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,119,HEDTA,O=C(O)CN(CCO)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"15,1",34,table S5,1,title,14,table S2
dioury2014,10.1021/ci500346w,10.1021/ja01582a007,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,119,HEDTA,O=C(O)CN(CCO)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"15,4",34,table S5,1,title,14,table S2
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(00)84982-8,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,120,HPED,O=C(O)CN(CCN(CC(=O)O)c1ccccc1O)c1ccccc1O,ligand,Gd,"21,18",34,table S5,1,title,14,table S2
dioury2014,10.1021/ci500346w,10.1021/ic9613016,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,121,BPED,O=C(O)CN(CCN(CC(=O)O)Cc1ccccn1)Cc1ccccn1,ligand,Gd,"12,37",34,table S5,1,title,14,table S2
dioury2014,10.1021/ci500346w,10.1021/ic00006a021,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,122,HEHA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"22,95",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1021/ic00006a021,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,123,PEPA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"15,88",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1021/ic00046a015,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,124,DTPA-EAM,O=C(O)CN1CCN(CC(=O)O)CC(=O)NCCNC(=O)CN(CC(=O)O)CC1,ligand,Gd,"11,15",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1021/ic00091a032,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,124,DTPA-EAM,O=C(O)CN1CCN(CC(=O)O)CC(=O)NCCNC(=O)CN(CC(=O)O)CC1,ligand,Gd,"11,4",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.5012/jkcs.2004.48.6.577,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,125,N-ac3[15]aneN3O2-bis,O=C(O)CN1CCOCCOCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"9,98",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.5012/jkcs.2004.48.6.577,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,126,N-pr3[15]aneN3O2-bis,O=C(O)CCN1CCOCCOCCN(CCC(=O)O)CCN(CCC(=O)O)CC1,ligand,Gd,"16,57",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1006/mchj.1996.0026,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,127,N-pr3[15]aneN3O2,O=C(O)CCN1CCOCCN(CCC(=O)O)CCN(CCC(=O)O)CCOCC1,ligand,Gd,"11,23",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1016/j.tet.2006.10.024,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,128,cyclo-PCTA12,O=C(O)CN1CCN(CC(=O)O)C2CCCCC2N(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,,34,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1016/j.tet.2009.06.117,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,129,amido-cyclo-PCTA12,O=C(O)CN1CC(=O)NC2CCCCC2N(CC(=O)O)Cc2cccc(n2)C1,ligand,Gd,,34,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1007/bf02594595,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,130,P730-1,O=C(O)CCC(C(=O)O)N1CCN(CC(=O)O)CCN(C(CCC(=O)O)C(=O)O)CCN(C(CCC(=O)O)C(=O)O)CC1,ligand,Gd,,34,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1021/ja101518v,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,131,DOTA(GA)2,O=C(O)CCC(C(=O)O)N1CCN(CC(=O)O)CCN(CC(=O)O)CCN(C(CCC(=O)O)C(=O)O)CC1,ligand,Gd,,34,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1021/ja101518v,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,132,DOTAGA,O=C(O)CCC(C(=O)O)N1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,,34,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1002/hlca.200590044,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,133,DOTABA,O=C(O)CN1CCN(CC(=O)O)CCN(C(C(=O)O)c2ccc(C(=O)O)cc2)CCN(CC(=O)O)CC1,ligand,Gd,,34,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1002/hlca.200590044,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,134,DOTASA,O=C(O)CC(C(=O)O)N1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"27,2",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1016/j.tetlet.2012.11.151,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,135,DOTA-hydrazide,NNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,,34,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1021/ic00038a023,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,136,DO3A-L1,CN(CC(O)C(O)C(O)C(O)CO)C(=O)C(COCc1ccccc1)N1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Gd,"26,4",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1021/ic00038a023,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,137,DO3A-L2,O=C(O)CN1CCN(CC(=O)O)CCN(C(COCc2ccccc2)C(=O)NC(CO)CO)CCN(CC(=O)O)CC1,ligand,Gd,"25,9",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1021/ic00065a019,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,138,"(R,R,R)-DO3MA",CC(C(=O)O)N1CCNCCN(C(C)C(=O)O)CCN(C(C)C(=O)O)CC1,ligand,Gd,"25,3",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1039/a803565b,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,139,DO2A,O=C(O)CN1CCNCCN(CC(=O)O)CCNCC1,ligand,Gd,"13,06",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1021/ic961131x,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,139,DO2A,O=C(O)CN1CCNCCN(CC(=O)O)CCNCC1,ligand,Gd,"19,1",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1021/ic961131x,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,139,DO2A,O=C(O)CN1CCNCCN(CC(=O)O)CCNCC1,ligand,Gd,"19,4",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1021/ic202436j,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,140,DODPA,O=C(O)c1cccc(CN2CCNCCN(Cc3cccc(C(=O)O)n3)CCNCC2)n1,ligand,Gd,,34,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1021/ic202436j,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,141,MeDODPA,CN1CCN(Cc2cccc(C(=O)O)n2)CCN(C)CCN(Cc2cccc(C(=O)O)n2)CC1,ligand,Gd,,34,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1016/0022-1902(81)80122-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,142,TTHA,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"19,51",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1016/0223-5234(88)90094-3,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,142,TTHA,O=C(O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"28,4",34,table S5,1,title,21,table S3
dioury2014,10.1021/ci500346w,10.1021/jm980152t,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,143,PNP-DTPA,O=C(O)CN(CCN(CC(=O)O)CC(Cc1ccc([N+](=O)[O-])cc1)N(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,,35,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1021/jm980152t,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,144,PNPM-DTPA,CC(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(Cc1ccc([N+](=O)[O-])cc1)N(CC(=O)O)CC(=O)O,ligand,Gd,,35,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1021/ic951326p,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,145,rac-trans-CHX-DTPA,O=C(O)CN(CCN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,,35,table S5,1,title,,
dioury2014,10.1021/ci500346w,10.1007/bf00759053,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,146,CEDTA,O=C(O)CCN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"16,71",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1007/bf00759053,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,146,CEDTA,O=C(O)CCN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"18,4",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1002/chem.200204612,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,147,EPTPA,O=C(O)CN(CCCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"17,5",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1002/chem.200204612,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,147,EPTPA,O=C(O)CN(CCCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"18,75",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1039/a805837g,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,147,EPTPA,O=C(O)CN(CCCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Gd,"22,77",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1002/1522-2675(200204)85:4<1033::aid-hlca1033>3.0.co;2-n,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,148,(S)-EPTPA-bz,O=C(O)CN(CCCN(CC(=O)O)CC(Cc1ccccc1)N(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"23,79",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1039/b107456n,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,149,TTDA-PY,O=C(O)CN(CCCN(CCN(CC(=O)O)CC(=O)O)Cc1ccccn1)CC(=O)O,ligand,Gd,"23,48",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1097/00004424-199009001-00026,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,150,DTPA-BEA,CCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCC)CC(=O)O)CC(=O)O,ligand,Gd,"15,34",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1097/00004424-199009001-00026,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,151,DTPA-BHeptA,CCCCCCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCCCCCC)CC(=O)O)CC(=O)O,ligand,Gd,"15,62",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1097/00004424-199111001-00074,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,152,DTPA-MPEA2,O=C(O)CN(CCN(CC(=O)O)CC(=O)NCCN1CCOCC1)CCN(CC(=O)O)CC(=O)NCCN1CCOCC1,ligand,Gd,"16,1",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1097/00004424-199009001-00026,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,152,DTPA-MPEA2,O=C(O)CN(CCN(CC(=O)O)CC(=O)NCCN1CCOCC1)CCN(CC(=O)O)CC(=O)NCCN1CCOCC1,ligand,Gd,"20,82",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1002/mrm.1910080208,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,153,DTPA-APD,O=C(O)CN(CCN(CC(=O)O)CC(=O)NCC(O)CO)CCN(CC(=O)O)CC(=O)NCC(O)CO,ligand,Gd,"15,32",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1097/00004424-199111001-00074,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,154,DTPA-BMMOA,CN(CCN1CCOCC1)C(=O)CN(CCN(CCN(CC(=O)O)CC(=O)N(C)CCN1CCOCC1)CC(=O)O)CC(=O)O,ligand,Gd,"20,3",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1016/0022-1902(71)80023-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,155,rac-trans-BDTA,CC(C(C)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Gd,"18,64",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1016/s0003-2670(01)95804-0,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,155,rac-trans-BDTA,CC(C(C)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Gd,"18,78",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1021/ac60243a032,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,155,rac-trans-BDTA,CC(C(C)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Gd,"18,84",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1016/0022-1902(71)80024-6,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,155,rac-trans-BDTA,CC(C(C)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Gd,"16,51",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1016/0022-1902(71)80023-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,155,rac-trans-BDTA,CC(C(C)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Gd,"17,03",35,table S5,1,title,22,table S3
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(00)80040-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,156,ENDPDA,O=C(O)CCN(CCN(CCC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"11,83",35,table S5,1,title,23,table S3
dioury2014,10.1021/ci500346w,10.1016/s0020-1693(00)80040-7,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,156,ENDPDA,O=C(O)CCN(CCN(CCC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"13,21",35,table S5,1,title,23,table S3
dioury2014,10.1021/ci500346w,10.1016/0022-1902(81)80122-4,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,156,ENDPDA,O=C(O)CCN(CCN(CCC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"15,35",35,table S5,1,title,23,table S3
dioury2014,10.1021/ci500346w,10.1021/j100808a028,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,157,EEDTA,O=C(O)CN(CCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"18,13",35,table S5,1,title,23,table S3
dioury2014,10.1021/ci500346w,10.1021/j100808a028,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,157,EEDTA,O=C(O)CN(CCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"18,21",35,table S5,1,title,23,table S3
dioury2014,10.1021/ci500346w,10.1007/978-1-4613-4452-0,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,157,EEDTA,O=C(O)CN(CCOCCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Gd,"18,3",35,table S5,1,title,23,table S3
dioury2014,10.1021/ci500346w,10.1016/0020-1693(94)04012-5,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,158,HBED,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)Cc1ccccc1O,ligand,Gd,"18,89",35,table S5,1,title,23,table S3
dioury2014,10.1021/ci500346w,10.1515/ci.2000.22.1.24a,1,QSPR Prediction of the Stability Constants of Gadolinium(III) Complexes for Magnetic Resonance Imaging,American Chemical Society (ACS),2014,0,158,HBED,O=C(O)CN(CCN(CC(=O)O)Cc1ccccc1O)Cc1ccccc1O,ligand,Gd,"19,16",35,table S5,1,title,23,table S3
bartholoma2010,10.1021/cr1000755,10.1021/cr1000755,0,Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era,American Chemical Society (ACS),2010,0,,TRODAT,CN1C2CCC1C(CN(CC[S-])CCNCC[S-])C(c1ccc(Cl)cc1)C2.[O-],environment,Tc,,4,figure 3,3,subtitle 2,,
bartholoma2010,10.1021/cr1000755,10.1021/cr1000755,0,Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era,American Chemical Society (ACS),2010,0,,tretroformin,CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[O-2].[O-2],environment,Tc,,4,figure 2,3,subtitle 2,,
bartholoma2010,10.1021/cr1000755,10.1021/cr1000755,0,Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era,American Chemical Society (ACS),2010,0,,bicisate,CCOC(=O)C([N-]CCNC(C(=O)OCC)C(C)(C)[S-])C(C)(C)[S-].[O-2],environment,Tc,,4,figure 2,3,subtitle 2,,
bartholoma2010,10.1021/cr1000755,10.1021/cr1000755,0,Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era,American Chemical Society (ACS),2010,0,,MAG3,O=C(O)C[N-]C(=O)C[N-]C(=O)C[N-]C(=O)C[S-].[O-2],environment,Tc,,4,figure 2,3,subtitle 2,,
bartholoma2010,10.1021/cr1000755,10.1021/cr1000755,0,Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era,American Chemical Society (ACS),2010,0,,sestamibi,[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC,environment,Tc,,4,figure 2,3,subtitle 2,,
bartholoma2010,10.1021/cr1000755,10.1021/cr1000755,0,Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era,American Chemical Society (ACS),2010,0,,teboroxime,C[B-](ON=C1CCCCC1=N[O-])(ON=C1CCCCC1=NO)ON=C1CCCCC1=NO.[Cl-],environment,Tc,,4,figure 2,3,subtitle 2,,
bartholoma2010,10.1021/cr1000755,10.1021/cr1000755,0,Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era,American Chemical Society (ACS),2010,0,,oxo,[O-2].[S-]CCNCCNCC[S-],environment,Tc,,5,figure 6,3,subtitle 2,,
bartholoma2010,10.1021/cr1000755,10.1021/cr1000755,0,Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era,American Chemical Society (ACS),2010,0,,tricarbonyl,N=Nc1ccccn1.[N-2]Nc1cccc[nH+]1.[S-]CCSCC[S-],environment,Tc,,5,figure 6,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,,DTPA,O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-],environment,Tc,,3,figure 1,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,,EHIDA,CCc1cccc(CC)c1NC(=O)CN(CC(=O)O)CC(=O)O,ligand,Tc,,3,figure 1,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,,MDP,O=P([O-])(O)CP(=O)([O-])O.O=P([O-])(O)CP(=O)([O-])O.[OH-].[OH-],environment,Tc,,3,figure 1,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,,MAG3,O=C(O)C[N-]C(=O)C[N-]C(=O)C[N-]C(=O)C[S-].[O-2],environment,Tc,,4,figure 2,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,3A,sestamibi,[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC,environment,Tc,,5,figure 3,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,3B,tretroformin,CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[O-2].[O-2],environment,Tc,,5,figure 3,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,3C,,COCCCP(CCCOC)CCCOC.COCCCP(CCCOC)CCCOC.C[N+](=CC1=C([O-])C(C)(C)OC1(C)C)CC[N+](C)=CC1=C([O-])C(C)(C)OC1(C)C,environment,Tc,,5,figure 3,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,3D,teboroxime,C[B-](ON=C1CCCCC1=N[O-])(ON=C1CCCCC1=NO)ON=C1CCCCC1=NO.[Cl-],environment,Tc,,5,figure 3,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,3E,,CCN(C(=S)[S-])C(C)(C)OC.CCN(C(=S)[S-])C(C)(C)OC.[N-3],environment,Tc,,5,figure 3,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,4A,HMPAO,CC(=N[O-])C(C)(C)[N-]CC(C)(C)C[N-]C(C)(C)C(C)=NO,environment,Tc,,6,figure 4,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,4B,ECD,CCOC(=O)C([N-]CCNC(C(=O)OCC)C(C)(C)[S-])C(C)(C)[S-],environment,Tc,,6,figure 4,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,4C,BATO,CC([O-])=CC(C)[N-]CC[N-]CC1=CCC=N1.[O-2],environment,Tc,,6,figure 4,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,6A,,CN1C2CCC1C(C(C[S-])[N-]CCNCC[S-])C(c1ccc(Cl)cc1)C2.[O-2],environment,Tc,,7,figure 6,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,6B,,COC(=O)C1C(c2ccc(Cl)cc2)CC2CCC1N2CCCN(CC[S-])CC[N-]CC[S-].[O-2],environment,Tc,,7,figure 6,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,6C,,COc1ccccc1N1CCN(CCN(CC[S-])CC(=O)[N-]CC[S-])CC1.[O-2],environment,Tc,,7,figure 6,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,8A,HYNIC,NNc1ccc(C(=O)O)cn1,ligand,Tc,,9,figure 8,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,9A,,NC(Cc1c[nH]cn1)C(=O)[O-].[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,10,figure 9,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,9B,,C1CSCCSCCS1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,10,figure 9,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,9C,,[C-]#[O+].[C-]#[O+].[C-]#[O+].c1cc[cH-]c1,environment,Tc,,10,figure 9,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,9E,,CSCCSCCC(=O)OCC1C(c2ccc(F)cc2)CC2CCC1N2C.[C-]#[O+].[C-]#[O+].[C-]#[O+].[Cl-],environment,Tc,,10,figure 9,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,9E,,CSCCSCCC(=O)OCC1C(c2ccc(F)cc2)CC2CCC1N2C.[Br-].[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,10,figure 9,3,subtitle 2,,
abram2006,10.1590/S0103-50532006000800004,10.1590/S0103-50532006000800004,0,Technetium and rhenium: coordination chemistry and nuclear medical applications,FapUNIFESP (SciELO),2006,1,9F,,COC(=O)C1C(c2ccc(-c3ccc[cH-]3)cc2)CC2CCC1N2C.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,10,figure 9,3,subtitle 2,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,1a,Cardiolite,[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC,environment,Tc,,3,scheme 1,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,1b,Myoview,CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[O-2].[O-2],environment,Tc,,3,scheme 1,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,1c,TRODAT-1,CN1C2CCC1C(CN(CC[S-])CC[N-]CC[S-])C(c1ccc(Cl)cc1)C2.[O-2],environment,Tc,,3,scheme 1,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,1d,MAG3 Technescan,O=C(O)C[N-]C(=O)C[N-]C(=O)C[N-]C(=O)C[S-].[O-2],environment,Tc,,3,scheme 1,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,1e,ECD Neurolite,CCOC(=O)C([N-]CCNC(C(=O)OCC)C(C)(C)[S-])C(C)(C)[S-].[O-2],environment,Tc,,3,scheme 1,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,8a,diethylenetriamine,NCCNCCN.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,15,scheme 8,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,8b,ethylenediamine monoacetic acid,NCCNCC(=O)[O-].[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,15,scheme 8,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,8c,imino–diacetic acid,O=C([O-])CNCC(=O)[O-].[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,15,scheme 8,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,8d,nitrilotriacetic acid,O=C([O-])CN(CC(=O)[O-])CC(=O)O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,15,scheme 8,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,,(im)3(CO)3,[C-]#[O+].[C-]#[O+].[C-]#[O+].c1c[nH]cn1.c1c[nH]cn1.c1c[nH]cn1,environment,Tc,,16,scheme 9,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,,,O.O=C(O)c1ccccn1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,18,scheme 11,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,,,O.O=C(O)c1c[nH]cn1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,18,scheme 11,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,,,O.O=C(O)c1ccc(C(=O)O)nc1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,18,scheme 11,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,,,O.O=C(O)c1ccnc(C(=O)O)c1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,18,scheme 11,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,,,COc1ccccc1N1CCN(CCCN=Cc2ccccn2)CC1.[C-]#[O+].[C-]#[O+].[C-]#[O+].[Cl-],environment,Tc,,23,scheme 14,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,15a,,NC(Cc1c[nH]cn1)C(=O)O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,24,scheme 15,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,15b,,C1CSCCSCCS1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,24,scheme 15,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,15c,,[C-]#[O+].[C-]#[O+].[C-]#[O+].c1ccc2c(c1)ncn2CNCn1cnc2ccccc21,environment,Tc,,24,scheme 15,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,15d,,NCCNCCN.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,24,scheme 15,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,,,NCCNCC[N-]Cc1ccc2c3c1C=CC1=CC=CC(C=C2)C13.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,26,scheme 17,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,,,CC12CCC3c4ccc(O)cc4CCC3C1CCC2(O)C#Cc1cc[cH-]c1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,29,scheme 19,1,title,,
alberto2005,10.1007/b101223,10.1007/b101223,0,New Organometallic Technetium Complexes for Radiopharmaceutical Imaging,Springer Berlin Heidelberg,2005,0,20b,,COc1ccccc1N1CCN(CC(=O)c2cc[cH-]c2)CC1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,30,scheme 20,1,title,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,4A,HMPAO,CC(=N[O-])C(C)[N-]CC(C)(C)C[N-]C(C)C(C)=NO.[O-2],environment,Tc,,3,figure 4,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,4B,"CC(C)(C)[N+]#[C-].CC(C)(C)[N+]#[C-].CC(C)(C)[N+]#[C-].CC(C)(C)[N+]#[C-].O=C(O)C1=C(O)C=CC(/N=N/C(C=[F,Cl,Br,I]2)=CC=C2C3=[F,Cl,Br,I]C=C(/N=N/C4=CC=C(O)C(C(O)=O)=C4)C=C3)=C1",CCOC(=O)C(C[S-])[N-]CCNC(C[S-])C(=O)OCC.[O-2],environment,Tc,,3,figure 4,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,DMPE2Cl2,CP(C)CCP(C)C.CP(C)CCP(C)C.[Cl-].[Cl-],environment,Tc,,4,figure 9,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,10A,,CC(=N[O-])C(C)[N-]CC(C)(C)C[N-]C(C)C(C)=NO.[O-2],environment,Tc,,4,figure 10,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,10B,,CCOC(=O)C(C[S-])[N-]CCCNC(C[S-])C(=O)OCC.[O-2],environment,Tc,,4,figure 10,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,teboroxime,C[B-]1(ON=C2CCCCC2=NO)ON=C2CCCCC2=[N+]1O.[Cl-].[O-]N=C1CCCCC1=N[O-],environment,Tc,,5,figure 11,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,NOET,CCN(CC)C(=S)[S-].CCN(CC)C(=S)[S-].[N-3],environment,Tc,,5,figure 12,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,tetrofosmine,CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[O-2].[O-2],environment,Tc,,5,figure 13,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,Q12,CC1(C)OC(C)(C)C(C=NCCC=NC2=C([O-])C(C)(C)OC2(C)C)=C1[O-].COCCP(CCOC)CCOC.COCCP(CCOC)CCOC,environment,Tc,,5,figure 14,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,lidoferin,Cc1cccc(C)c1NC(=O)CN(CC(=O)[O-])CC(=O)[O-].Cc1cccc(C)c1NC(=O)CN(CC(=O)[O-])CC(=O)[O-],environment,Tc,,6,figure 17,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,disoferin,Cc1cc(C(C)C)c(NC(=O)CN(CC(=O)[O-])CC(=O)[O-])c(C(C)C)c1.Cc1cc(C(C)C)c(NC(=O)CN(CC(=O)[O-])CC(=O)[O-])c(C(C)C)c1,environment,Tc,,6,figure 17,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,mebroferin,Cc1cc(C)c(NC(=O)CN(CC(=O)[O-])CC(=O)[O-])c(C)c1Br.Cc1ccc(NC(=O)CN(CC(=O)[O-])CC(=O)[O-])c(C)c1Br,environment,Tc,,6,figure 17,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,glucoheptonate,O=C([O-])C([O-])C(O)C(O)C(O)C(O)CO.O=C([O-])C([O-])C(O)C(O)C(O)C(O)CO.[O-2],environment,Tc,,6,figure 19,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,DMSA,O=C(O)C([S-])C([S-])C(=O)O.O=C(O)C([S-])C([S-])C(=O)O.[O-2],environment,Tc,,7,figure 20,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,21A,DTPA,O=C([O-])CN(CCN1CC(=O)C1CN(CC(=O)[O-])CC(=O)O)CC(=O)O.[O-],environment,Tc,,7,figure 21,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,21B,DPTA,CCN(CCN(CCN(CC(=O)[O-])CC(=O)O)CC(=O)O)CC(=O)[O-].[O-2],environment,Tc,,7,figure 21,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,MAG3,O=C(O)C[N-]C(=O)C[N-]C(=O)C[N-]C(=O)C[S-].[O-2],environment,Tc,,7,figure 22,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,23A,MDP,O=P(O)(O)CP(=O)(O)O,ligand,Tc,,7,figure 23,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,23B,phenyl spacer,CC=CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(CN(CC[N-]CC(C)(C)[S-])CC(C)(C)[S-])cc3)CC21C.[O-2],environment,Tc,,8,figure 26,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,27A,,CC1CC[N-]C1(C)C[S-].O=C1CC[N-]C(C[S-])C1.[O-2],environment,Tc,,8,figure 27,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,27B,,CC(C)([S-])C[N-]c1ccc(O)cc1.[O-2].[S-]Cc1ccccn1,environment,Tc,,8,figure 27,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,29B,TRODAT,CN1C2CCC1C(CN(CC[S-])CC[N-]CC[S-])C(c1ccc(Cl)cc1)C2.[O-2],environment,Tc,,9,figure 29,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,34A,2-nitroimidazoles,CC(=NO)C(C)(C)[N-]CCC[N-]C(C)(C)C(Cn1ccnc1[N+](=O)[O-])=N[O-].[O-2],environment,Tc,,10,figure 34,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,34B,2-nitroimidazoles,CC(=N[O-])C(C)(C)[N-]CC(C[N-]C(C)(C)C(C)=NO)Cn1ccnc1[N+](=O)[O-].[O-2],environment,Tc,,10,figure 34,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,amineoxime ligand,CC(=NO)C(C)(C)NCCCCNC(C)(C)C(Cn1ccnc1[N+](=O)[O-])=NO,ligand,Tc,,10,figure 35,1,subtitle 2,,
dilworth1998,10.1039/A827043Z,10.1039/A827043Z,0,The biomedical chemistry of technetium and rhenium,Royal Society of Chemistry (RSC),1998,0,,,C=C(C[S-])[N-]CC(CCC(=O)NCCCCCC(=O)Nc1cc2cc(c1)C(=O)NC(C(C)C)C(=O)N(C)C(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC2)[N-]C(=C)C[S-].[O-2],environment,Tc,,11,figure 36,1,subtitle 2,,
eckelman2013,10.1016/j.drudis.2013.06.008,10.1016/j.drudis.2013.06.008,0,Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites,Elsevier BV,2013,0,,tebroxime,C[B-](ON=C1CCCCC1=N[O-])(ON=C1CCCCC1=NO)ON=C1CCCCC1=NO.[Cl-],environment,Tc,,3,table 1,1,title,,
eckelman2013,10.1016/j.drudis.2013.06.008,10.1016/j.drudis.2013.06.008,0,Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites,Elsevier BV,2013,0,,sestamibi,[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC,environment,Tc,,3,table 1,1,title,,
eckelman2013,10.1016/j.drudis.2013.06.008,10.1016/j.drudis.2013.06.008,0,Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites,Elsevier BV,2013,0,,tetrofosmine,CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[O-2].[O-2],environment,Tc,,3,table 1,1,title,,
eckelman2013,10.1016/j.drudis.2013.06.008,10.1016/j.drudis.2013.06.008,0,Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites,Elsevier BV,2013,0,,exametazime,CC(=N[O-])C(C)[N-]CC(C)(C)C[N-]C(C)C(C)=NO.[O-2],environment,Tc,,3,table 1,1,title,,
eckelman2013,10.1016/j.drudis.2013.06.008,10.1016/j.drudis.2013.06.008,0,Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites,Elsevier BV,2013,0,,bicisate,CCOC(=O)C(C[S-])[N-]CCNC(C[S-])C(=O)OCC.[O-2],environment,Tc,,3,table 1,1,title,,
eckelman2013,10.1016/j.drudis.2013.06.008,10.1016/j.drudis.2013.06.008,0,Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites,Elsevier BV,2013,0,,mertiatide,O=C(O)C[N-]C(=O)C[N-]C(=O)C[N-]C(=O)C[S-].[O-2],environment,Tc,,3,table 1,1,title,,
eckelman2013,10.1016/j.drudis.2013.06.008,10.1016/j.drudis.2013.06.008,0,Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites,Elsevier BV,2013,0,,TRODAT1,CN1C2CCC1C(CN(CC[S-])CC[N-]CC[S-])C(c1ccc(Cl)cc1)C2.[O-],environment,Tc,,3,table 1,1,title,,
eckelman2013,10.1016/j.drudis.2013.06.008,10.1016/j.drudis.2013.06.008,0,Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites,Elsevier BV,2013,0,,depreotide,CC(C)C1NC(=O)C(CCCCN)CC(=O)C(Cc2cc3ccccc3[nH]2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(Cc2ccccc2)N(C)C(=O)C(CCSCC(=O)NCC([NH-])C(=O)[N-]C(CCCCN)C(=O)[N-]C(C[S-])C(=O)NC(CCCCN)C(N)=O)NC1=O.[O-2],environment,Tc,,4,table 1,1,title,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,,HMPAO,CC(=N[O-])C(C)[N-]CC(C)(C)C[N-]C(C)C(C)=NO.[O-2],environment,Tc,,7,figure 7,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,,ECD,CCOC(=O)C(C[S-])[N-]CCNC(C[S-])C(=O)OCC.[O-2],environment,Tc,,8,figure 8,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,,TRODAT-1,CN1C2CCC1C(CN(CC[S-])CC[N-]CC[S-])C(c1ccc(Cl)cc1)C2.[O-2],environment,Tc,,8,figure 10,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L2,,Nc1c(N=Nc2ccc(-c3ccc(N=Nc4cc(S(=O)(=O)O[Na])c5ccccc5c4N)cn3)nc2)cc(S(=O)(=O)O[Na])c2ccccc12.[C-]#[N+]C(C)(C)C.[C-]#[N+]C(C)(C)C.[C-]#[N+]C(C)(C)C.[C-]#[N+]C(C)(C)C,environment,Tc,,9,figure 11,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L3,,O=C(O)c1cc(N=Nc2ccc(-c3ccc(N=Nc4ccc(O)c(C(=O)O)c4)cn3)nc2)ccc1O.[C-]#[N+]C(C)(C)C.[C-]#[N+]C(C)(C)C.[C-]#[N+]C(C)(C)C.[C-]#[N+]C(C)(C)C,environment,Tc,,9,figure 11,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L4,,O=C(CN(CC[S-])CC(=O)Nc1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1-c1ccc(N=Nc2ccc(O)c(C(=O)O)c2)cc1)[N-]CC[S-].[O-2],environment,Tc,,9,figure 12,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L5,,CN(C)c1ccc(-c2ccc([N-]CC[S-])c(C=NCC[S-])c2)cc1.[O-2],environment,Tc,,10,figure 13,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L5,,CN(C)c1ccc(-c2ccc([N-]C(=O)C[S-])c(C=NCC[S-])c2)cc1.[O-2],environment,Tc,,10,figure 13,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L5,,CN(C)c1ccc(-c2ccc([N-]C(=O)C[S-])c(C=NCC(C)(C)[S-])c2)cc1.[O-2],environment,Tc,,10,figure 13,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L5,,CN(C)c1ccc(-c2ccc([N-]CC[S-])c(C=NCC(C)(C)[S-])c2)cc1.[O-2],environment,Tc,,10,figure 13,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L6,,O=C(CN(CC[S-])CC[N-]CC[S-])Nc1ccc(-c2nc3ccccc3s2)cc1.[O-2],environment,Tc,,10,figure 14,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L7,,Nc1ccc(-c2nc3ccc(OCCCCCN(CC[S-])CC(=O)[N-]CC[S-])cc3s2)cc1.[O-2],environment,Tc,,10,figure 14,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L8,,CN(C)c1ccc(C=CC(=O)c2ccc(OCCCN(CC[S-])CC(=O)[N-]CC[S-])cc2)cc1.[O-2],environment,Tc,,11,figure 15,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L8,,CN(C)c1ccc(C=CC(=O)c2ccc(OCCCN(CC[S-])CC[N-]CC[S-])cc2)cc1.[O-2],environment,Tc,,11,figure 15,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L8,,CN(C)c1ccc(C=CC(=O)c2ccc(OCCCCCN(CC[S-])CC[N-]CC[S-])cc2)cc1.[O-2],environment,Tc,,11,figure 15,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L8,,CN(C)c1ccc(C=CC(=O)c2ccc(OCCCCCN(CC[S-])CC(=O)[N-]CC[S-])cc2)cc1.[O-2],environment,Tc,,11,figure 15,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L9,,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCN(CC[S-])CC[N-]CC[S-])cc3o2)cc1.[O-2],environment,Tc,,11,figure 15,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L10,,CN(C)c1ccc(C=C2Oc3cc(OCCCN(CC[S-])CC[N-]CC[S-])ccc3C2=O)cc1.[O-2],environment,Tc,,11,figure 15,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L11,,CN(C)c1ccc(-c2cc3cc(OCCCN(CC[S-])CC[N-]CC[S-])ccc3o2)cc1.[O-2],environment,Tc,,11,figure 15,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L12,,CN(C)c1ccc(-c2cc3cc(OCCCN(CC[S-])CC(=O)[N-]CC[S-])ccc3o2)cc1.[O-2],environment,Tc,,11,figure 15,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L13,,CC(=O)c1ccc2cc(N(C)CCN(CC[S-])CC(=O)[N-]CC[S-])ccc2c1.[O-2],environment,Tc,,11,figure 16,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L14,,CC(=C(C#N)C#N)c1ccc2cc(N(C)CCN(CC[S-])CC(=O)[N-]CC[S-])ccc2c1.[O-2],environment,Tc,,11,figure 16,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L15,,COc1cc(C=CC([O-])CC([O-])C=Cc2ccc(O)c(OC)c2)ccc1O.[C-]#[O+].[C-]#[O+].[C-]#[O+].[OH-],environment,Tc,,12,figure 17,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L15,,COc1cc(C=CC([O-])CC([O-])C=Cc2ccc(O)c(OC)c2)ccc1O.[C-]#[O+].[C-]#[O+].[C-]#[O+].c1c[n-]cn1,environment,Tc,,12,figure 17,6,subtitle 7,,
hickey2012,10.1016/j.ccr.2012.03.035,10.1016/j.ccr.2012.03.035,0,Diagnostic imaging of Alzheimer's disease with copper and technetium complexes,Elsevier BV,2012,0,L15,,COc1cc(C=CC([O-])CC([O-])C=Cc2ccc(O)c(OC)c2)ccc1O.[C-]#[N+]C1CCCCC1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,12,figure 17,6,subtitle 7,,
hjelstuen1995,10.1039/AN9952000863,10.1039/AN9952000863,0,Technetium-99m chelators in nuclear medicine. A review,Royal Society of Chemistry (RSC),1995,0,,MDP,O=P(O)(O)CP(=O)(O)O,ligand,Tc,,2,figure,1,title,,
hjelstuen1995,10.1039/AN9952000863,10.1039/AN9952000863,0,Technetium-99m chelators in nuclear medicine. A review,Royal Society of Chemistry (RSC),1995,0,,MDP,O=P([O-])(O)CP(=O)([O-])O.O=P([O-])(O)CP(=O)([O-])O.[OH-].[OH-],environment,Tc,,2,figure,1,title,,
hjelstuen1995,10.1039/AN9952000863,10.1039/AN9952000863,0,Technetium-99m chelators in nuclear medicine. A review,Royal Society of Chemistry (RSC),1995,0,,ECD,CCOC(=O)C(C[S-])[N-]CCNC(C[S-])C(=O)OCC.[O-2],environment,Tc,,2,figure,1,title,,
hjelstuen1995,10.1039/AN9952000863,10.1039/AN9952000863,0,Technetium-99m chelators in nuclear medicine. A review,Royal Society of Chemistry (RSC),1995,0,,HMPAO,CC(=NO)C(C)=NCC(C)(C)CN=C(C)C(C)=NO,environment,Tc,,2,figure,1,title,,
hjelstuen1995,10.1039/AN9952000863,10.1039/AN9952000863,0,Technetium-99m chelators in nuclear medicine. A review,Royal Society of Chemistry (RSC),1995,0,,hexaMIBI,[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC,environment,Tc,,2,figure,1,title,,
hjelstuen1995,10.1039/AN9952000863,10.1039/AN9952000863,0,Technetium-99m chelators in nuclear medicine. A review,Royal Society of Chemistry (RSC),1995,0,,DTPA,O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[O-2],environment,Tc,,3,figure,1,title,,
hjelstuen1995,10.1039/AN9952000863,10.1039/AN9952000863,0,Technetium-99m chelators in nuclear medicine. A review,Royal Society of Chemistry (RSC),1995,0,,MAG3,O=C(O)C[N-]C(=O)C[N-]C(=O)C[N-]C(=O)C[S-].[O-2],environment,Tc,,3,figure,1,title,,
hjelstuen1995,10.1039/AN9952000863,10.1039/AN9952000863,0,Technetium-99m chelators in nuclear medicine. A review,Royal Society of Chemistry (RSC),1995,0,,DMSA,O=C(O)C([S-])C([S-])C(=O)O.O=C(O)C([S-])C([S-])C(=O)O,environment,Tc,,3,figure,1,title,,
hjelstuen1995,10.1039/AN9952000863,10.1039/AN9952000863,0,Technetium-99m chelators in nuclear medicine. A review,Royal Society of Chemistry (RSC),1995,0,,mebrofenin,Cc1cc(C)c(NC(=O)CN(CC(=O)[O-])CC(=O)[O-])c(C)c1Br.Cc1cc(C)c(NC(=O)CN(CC(=O)[O-])CC(=O)[O-])c(C)c1Br,environment,Tc,,3,figure,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,Sestamibi,[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC,environment,Tc,,4,figure 3,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,Tetrofosmin,CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[O-2].[O-2],environment,Tc,,4,figure 3,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,HMPAO,CC(=N[O-])C(C)[N-]CC(C)(C)C[N-]C(C)C(C)=NO.[O-2],environment,Tc,,4,figure 3,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,ECD,CCOC(=O)C([N-]CCNC(C(=O)OCC)C(C)(C)[S-])C(C)(C)[S-].[O-2],environment,Tc,,4,figure 3,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,MAG3,O=C(O)C[N-]C(=O)C[N-]C(=O)C[N-]C(=O)C[S-].[O-2],environment,Tc,,4,figure 3,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,TRODAT-1,CN1C2CCC1C(CN(CC[S-])CC[N-]CC[S-])C(c1ccc(Cl)cc1)C2.[O-2],environment,Tc,,5,figure 4,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,Tektrotyd,C=C1NC(C(C)O)C(=O)NC(C(=C)NC(CO)C(C)O)CSSCC(NC(=O)C(NC(=O)c2ccc(N=[N-])nc2)c2ccccc2)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC1CCCCN.O=C([O-])C[N-]CC[N-]CC(=O)[O-],environment,Tc,,5,figure 4,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,DADT,[O-2].[S-]CC[N-]CCNCC[S-],environment,Tc,,6,figure 7,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,MAMA,O=C(CNCC[S-])[N-]CC[S-].[O-2],environment,Tc,,6,figure 7,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,DADS,O=C(C[S-])[N-]CC[N-]C(=O)C[S-].[O-2],environment,Tc,,6,figure 7,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,(acac)2en,CC([O-])=CC(C)=NCCN=C(C)C=C(C)[O-].[O-2].[O],environment,Tc,,6,figure 9,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,furifosmin,CC1(C)OC(C)(C)C(C=NCCN=CC2=C([O-])C(C)(C)OC2(C)C)=C1[O-].COCCCP(CCCOC)CCCOC.COCCCP(CCCOC)CCCOC,environment,Tc,,6,figure 9,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,CC1(C[S-])[N-]CCC1O.CN1CCC(=O)CC1C[S-].[O-2],environment,Tc,,6,figure 10,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,glucoheptate,O=C([O-])C([O-])C(O)C(O)C(O)C(O)CO.O=C([O-])C([O-])C(O)C(O)C(O)C(O)CO.[O-2],environment,Tc,,7,figure 11,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,endo-DMSA,O=C(O)C([S-])C([S-])C(=O)O.O=C(O)C([S-])C([S-])C(=O)O.[O-2],environment,Tc,,7,figure 11,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,exo-DMSA,O=C(O)C([S-])C([S-])C(=O)O.O=C(O)C([S-])C([S-])C(=O)O.[O-2],environment,Tc,,7,figure 11,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,anti-DMSA,O=C(O)C([S-])C([S-])C(=O)O.O=C(O)C([S-])C([S-])C(=O)O.[O-2],environment,Tc,,7,figure 11,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,tetramine,NCCNCCCNCCN.[O-2].[O-2],environment,Tc,,7,figure 12,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,OCP(CO)CCSCCCSCCP(CO)CO.[O-2].[O-2],environment,Tc,,7,figure 12,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,OCP(CO)CCNCCCNCCP(CO)CO.[O-2].[O-2],environment,Tc,,7,figure 12,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,NOET,CCON(CC)C(=S)[S-].CCON(CC)C(=S)[S-].[N-3],environment,Tc,,7,figure 13,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,(HYNIC)(tricine)2,O=C([O-])C[N-]C(CO)(CO)CO.O=C([O-])C[N-]C(C[O-])(CO)CO.[N-]=Nc1ccc(C(=O)O)cn1,environment,Tc,,8,figure 14,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,(HYNIC)(EDDA),O=C([O-])CNCCNCC(=O)[O-].[N-]=Nc1ccc(C(=O)O)cn1,environment,Tc,,8,figure 14,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,(HYNIC)2(SNS),CN(CC[S-])CC[S-].[N-]=Nc1ccc(C(=O)O)cn1.[N-]=Nc1ccc(C(=O)O)cn1,environment,Tc,,8,figure 14,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,2,,NC(Cc1c[nH]cn1)C(=O)[O-].[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,9,figure 16,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,2,,NC(Cc1c[nH]nn1)C(=O)[O-].[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,9,figure 16,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,6,,O=C([O-])c1ccccn1.[C-]#[O+].[C-]#[O+].[C-]#[O+].c1c[nH]cn1,environment,Tc,,9,figure 16,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,c1cn(CCNCCn2ccnc2)cn1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,c1cn(CCNCCn2ccnn2)nn1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,c1cnn(CCNCCn2cccn2)c1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,c1cc[n+](CCNCC[n+]2ccccc2)cc1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,NCCNCCN,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,c1cn(CCSCCn2ccnc2)cn1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,c1cn(CCSCCn2ccnn2)nn1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,c1cnn(CCSCCn2cccn2)c1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,c1cc[n+](CCSCC[n+]2ccccc2)cc1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,NCCSCCN,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,O=C(O)CNCCn1ccnc1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,O=C(O)CNCCn1ccnn1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,O=C(O)CNCCn1cccn1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,O=C(O)CNCC[n+]1ccccc1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,NCCNCC(=O)O,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,O=C(O)CSCCn1ccnc1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,O=C(O)CSCCn1ccnn1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,O=C(O)CSCCn1cccn1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,O=C(O)CSCC[n+]1ccccc1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,NCCSCC(=O)O,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,,O=C(O)C1=CC2C3CC(C=C3C(=O)O)C2C1,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,TMEOP,COCc1nn(C(n2nc(COC)c(COC)c2COC)n2nc(COC)c(COC)c2COC)c(COC)c1COC,ligand,Tc,,9,figure 17,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,depreotide,CC(C)C1NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(Cc2ccccc2)N(C)C(=O)C(CCSCC(=O)NCC(N)C(=O)[N-]C(CCCCN)C(=O)[N-]C(C[S-])C(=O)CC(CCCCN)C(N)=O)NC1=O.[O-2],environment,Tc,,11,figure 19,1,title,,
papagiannopoulou2017,10.1002/jlcr.3531,10.1002/jlcr.3531,0,Technetium‐99m radiochemistry for pharmaceutical applications,Wiley,2017,0,,MIP-1404,O=C(O)CCC(NC(=O)NC(CCC(=O)NC(CCCCN(Cc1nccn1CC(=O)N(CC(=O)O)CC(=O)O)Cc1nccn1CC(=O)N(CC(=O)O)CC(=O)O)C(=O)O)C(=O)O)C(=O)O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,11,figure 19,1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789 ,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,MIBI,[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC,environment,Tc,,2,figure 1,1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,Q12,CC1(C)OC(C)(C)C(C=NCCN=CC2=C([O-])C(C)(C)OC2(C)C)=C1[O-].COCCCP(CCCOC)CCCOC.COCCCP(CCCOC)CCCOC,environment,Tc,,2,figure 1,1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,P53,CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[O-2].[O-2],environment,Tc,,2,figure 1,1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789 ,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,(DIARS)2(SR1)2,CCC[S-].CCC[S-].C[As](C)c1ccccc1[As](C)C.C[As](C)c1ccccc1[As](C)C,environment,Tc,,2,"figure 1, 2",1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,(DIARS)2(SR2)2,COCC[S-].COCC[S-].C[As](C)c1ccccc1[As](C)C.C[As](C)c1ccccc1[As](C)C,environment,Tc,,2,"figure 1, 2",1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,(DIARS)2(SR3)2,COCC(C[S-])OC.COCC(C[S-])OC.C[As](C)c1ccccc1[As](C)C.C[As](C)c1ccccc1[As](C)C,environment,Tc,,2,"figure 1, 2",1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,(DIARS)2(SR4)2,CC1(C)OCC(C[S-])O1.CC1(C)OCC(C[S-])O1.C[As](C)c1ccccc1[As](C)C.C[As](C)c1ccccc1[As](C)C,environment,Tc,,2,"figure 1, 2",1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,(DIARS)2(SR5)2,C[As](C)c1ccccc1[As](C)C.C[As](C)c1ccccc1[As](C)C.[S-]CCC1OCCCO1.[S-]CCC1OCCCO1,environment,Tc,,2,"figure 1, 2",1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,(DIARS)2(SR6)2,COCC(CCC[S-])COC.COCC(CCC[S-])COC.C[As](C)c1ccccc1[As](C)C.C[As](C)c1ccccc1[As](C)C,environment,Tc,,2,"figure 1, 2",1,title,,
tisato1996,10.1021/jm9507789,10.1021/jm9507789,0,Cationic [<sup>99m</sup>Tc<sup>III</sup>(DIARS)<sub>2</sub>(SR)<sub>2</sub>]<sup>+</sup> Complexes as Potential Myocardial Perfusion Imaging Agents (DIARS = <i>o</i>-phenylenebis(dimethylarsine); SR<sup>-</sup> = thiolate),American Chemical Society (ACS),1996,0,,(DIARS)2(SR7)2,C[As](C)c1ccccc1[As](C)C.C[As](C)c1ccccc1[As](C)C.OCC[S-].OCC[S-],environment,Tc,,2,"figure 1, 2",1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,2a,,C=C(C[S-])[N-]CC(=O)[N-]CC(=O)[N-]CC(=O)[O-].[Na+].[Na+].[O-2],environment,Tc,,3,figure 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,2b,,CC(=N[O-])C(C)[N-]CC(C)(C)C[N-]C(C)C(C)=NO.[O-2],environment,Tc,,3,figure 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,2c,,CCOC(=O)C(C[S-])[N-]CCNC(C[S-])C(=O)OCC.[O-2],environment,Tc,,3,figure 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,2d,,CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[O-2].[O-2],environment,Tc,,3,figure 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,2e,,CCOCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[O-2].[O-2],environment,Tc,,3,figure 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,2f,,[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC.[C-]#[N+]CC(C)(C)OC,environment,Tc,,3,figure 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C1,,CC(=C(c1ccc(O)cc1)c1ccc(OCC(=O)[c-]2cccc2)cc1)c1ccc(O)cc1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,6,scheme 1,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C3a,,CC(C)CC(NC(=O)[c-]1cccc1)C(=O)NCC(=O)NCC(=O)O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,7,scheme 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C3b,,O=C(CNC(=O)C(CC1=CCC2=C1C=CCC=C2)NC(=O)[c-]1cccc1)NC(Cc1ccc(O)cc1)C(=O)O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,7,scheme 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C3c,,CC(C)CC(NC(=O)[c-]1cccc1)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,7,scheme 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C3d,,CSCCC(NC(=O)C(CCSC)NC(=O)C(CCSC)NC(=O)[c-]1cccc1)C(=O)O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,7,scheme 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C3e,,CC(C)CC(NC(=O)C(C)NC(=O)C(NC(=O)[c-]1cccc1)C(C)C)C(=O)O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,7,scheme 2,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C4-R2 ,,COc1ccccc1N1CCN(CCCNC(=O)c2cc[cH-]c2)CC1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,8,scheme 3,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C4-R3 ,,O=C(c1cc[cH-]c1)N1CCN(c2ccccc2)CC1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,8,scheme 3,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C5a,,COc1ccc([P+](CCCCCC(=O)[c-]2cccc2)(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,8,scheme 3,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C5b,,COc1cccc(OC)c1[P+](CCCCCC(=O)[c-]1cccc1)(c1c(OC)cccc1OC)c1c(OC)cccc1OC.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,8,scheme 3,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C7,,O=C(Nc1ccccc1)[c-]1cccc1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,9,scheme 4,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C8,,C[B-](ON=C1CCCCC1=N[O-])(ON=C1CCCCC1=NO)ON=C1CCCCC1=NO.[Cl-],environment,Tc,,10,scheme 5,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C10,,Cc1c2oc3c(C)ccc(C(=O)NC4C(=O)NC(C(C)C)C(=O)N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)c3nc-2c(C(=O)NC2C(=O)NC(C(C)C)C(=O)N3CCCC3C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC2C)c(N)c1=O,environment,Tc,,11,scheme 6,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C11a,MIPrDP,Cc1nccn1CCC(O)(P(=O)([O-])O)P(=O)([O-])O.Cc1nccn1CCC(O)(P(=O)([O-])O)P(=O)([O-])O,environment,Tc,,11,scheme 6,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C11b,MIBDP,Cc1nccn1CCCC(O)(P(=O)([O-])O)P(=O)([O-])O.Cc1nccn1CCCC(O)(P(=O)([O-])O)P(=O)([O-])O,environment,Tc,,11,scheme 6,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C11c,MIPeDP,Cc1nccn1CCCCC(O)(P(=O)([O-])O)P(=O)([O-])O.Cc1nccn1CCCCC(O)(P(=O)([O-])O)P(=O)([O-])O,environment,Tc,,11,scheme 6,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C12,,CCCCC[N+](CCCC)(CCCC)CCCC.Cl.O=C(C=C([O-])C(F)(F)F)C(F)(F)F.[Cl-].[Cl-],environment,Tc,,11,scheme 6,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C13,,C[N+]12CN3CN(CP(C3)C1)C2.C[N+]12CN3CN(CP(C3)C1)C2.[Cl-].[Cl-].[Cl-].[Cl-],environment,Tc,,12,scheme 7,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C14,,CN1[C]N(C)C=C1.CN1[C]N(C)C=C1.CN1[C]N(C)C=C1.CN1[C]N(C)C=C1.[O-2],environment,Tc,,12,scheme 8,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C15,,CC(COC(=O)C(C)(COC(=O)C(C)(COC(=O)C(C)(COC(=O)C(C)(CO)CO)COC(=O)C(C)(CO)CO)COC(=O)C(C)(COC(=O)C(C)(CO)CO)COC(=O)C(C)(CO)CO)COC(=O)C(C)(COC(=O)C(C)(COC(=O)C(C)(CO)CO)COC(=O)C(C)(CO)CO)COC(=O)C(C)(COC(=O)C(C)(CO)CO)COC(=O)C(C)(CO)CO)(COC(=O)C(C)(COC(=O)C(C)(COC(=O)C(C)(COC(=O)C(C)(CO)CO)COC(=O)C(C)(CO)CO)COC(=O)C(C)(COC(=O)C(C)(CO)CO)COC(=O)C(C)(CO)CO)COC(=O)C(C)(COC(=O)C(C)(COC(=O)C(C)(CO)CO)COC(=O)C(C)(CO)CO)COC(=O)C(C)(COC(=O)C(C)(CO)CO)COC(=O)C(C)(CO)CO)C(=O)NCCCCCCN(Cc1ccccn1)Cc1ccccn1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,13,scheme 9,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C16,,O=C(O)CCc1ccc(C(=O)CCCCCCCCCCCN(Cc2ccccn2)Cc2ccccn2)s1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,13,scheme 10,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C17,,CC1N=CC([N+](=O)[O-])=[N+]1CCC1C=C(CCN(Cc2ccccn2)Cc2ccccn2)N=N1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,13,scheme 10,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C18,,O=C(O)CCCCN(Cc1nccs1)Cc1nccs1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,15,scheme 11,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C19,,CC(=O)C1CCCCNC(=O)C(Cc2ccc(O)cc2)NC(=O)C(C)NC(=O)C[N]Cc2cccc(n2)C[N]CC(=O)NC(C)C(=O)NC(Cc2ccc(O)cc2)C(=O)N1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,15,scheme 11,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C20,,CC1=CN(C2CC(O)C(CO)O2)C(C)N(Cn2cc(CN3CCCNCCCNCCC3)nn2)C1=O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,16,scheme 12,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C21,,CN1C=C[N-]C1.O=S(=O)(O)c1ccc(-c2ccnc3c2ccc2c(-c4ccc(S(=O)(=O)O)cc4)ccnc23)cc1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,16,scheme 12,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C22,,O=C(CCCCN1C=C[N-]C1)NCCCC(P(=O)(O)O)(P(=O)(O)O)P(=O)(O)O.O=S(=O)(O)c1ccc(-c2ccnc3c2ccc2c(-c4ccc(S(=O)(=O)O)cc4)ccnc23)cc1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,16,scheme 12,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C23,,Cc1cc(C)n(CCN(CCN)CCCNC(=O)C(N)CCCNC(=N)N)n1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,17,scheme 13,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C24,,Cc1cc(C)n(CCN(CCN)CCCCCCNC(=O)C(N)CCCNC(=N)N)n1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,17,scheme 13,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C25,,CCCCC(=O)NCc1ccc(-c2nncnn2)cc1.[C-]#[O+].[C-]#[O+].[C-]#[O+].c1ccc(-c2ccccn2)nc1,environment,Tc,,18,scheme 14,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C26,,CCCCC(=O)NCc1ccc(-c2nncnn2)cc1.O=S(=O)([O-])c1ccc(-c2ccnc3c2ccc2c(-c4ccc(S(=O)(=O)[O-])cc4)ccnc23)cc1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,18,scheme 14,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C27,,COc1ccccc1N1CCN(CCC[n+]2cc(-c3ccccn3)[n-]n2)CC1.[C-]#[O+].[C-]#[O+].[C-]#[O+].[Cl-],environment,Tc,,18,scheme 15,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C28,,C1N2CN3CN1CP(C2)C3.C1N2CN3CN1CP(C2)C3.[C-]#[O+].[C-]#[O+].[C-]#[O+].[Cl-],environment,Tc,,18,scheme 16,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C29,N4IPA,NC(C[N+]1=CNC([N+](=O)[O-])C1)=N[O-].NC(C[N+]1=CNC([N+](=O)[O-])C1)=N[O-].[O-2],environment,Tc,,19,scheme 17,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C30,,O=C(O)CNCCNCC(=O)O.O=C([O-])CNC([O-])(O)CO.[N-2]Nc1ccc(C(=O)NC2C(O)OC(CO)C(O)C2O)cn1,environment,Tc,,19,scheme 17,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C32a,BOD,CC1=CC(C)=[N+]2C1=C(c1ccc(C(N)=N[O-])cc1)c1c(C)cc(C)n1[B-]2(F)F.CC1=CC(C)=[N+]2C1=C(c1ccc(C(N)=N[O-])cc1)c1c(C)cc(C)n1[B-]2(F)F.[O-2],environment,Tc,,21,scheme 19,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C32b,MBOD,CNC(=N[O-])c1ccc(C2C3=C(C)C=C(C)C3[B-](F)(F)C3=C(C)C=C(C)C32)cc1.CNC(=N[O-])c1ccc(C2C3=C(C)C=C(C)C3[B-](F)(F)C3=C(C)C=C(C)C32)cc1.[O-2],environment,Tc,,21,scheme 19,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C33,,O=C([O-])CN1CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC1.[O-2].[O-2].[O-2],environment,Tc,,21,scheme 19,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C35,,C=C(NCCCC(NCCCCc1ccc(N(CCCl)CCCl)cc1)C(=O)NC1CSSCC(C(N)=O)C(=O)C(CCNC(=N)N)NC(=O)CNC(=O)C(CC(N)=O)NC1=O)c1ccc(N=N)nc1.O=C(O)CNCCNCC(=O)O.O=C([O-])CNCCNCC(=O)O,environment,Tc,,22,scheme 21,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C36,,CC1(C)OC(C)(C)C(C=NCCN=CC2=C([O-])C(C)(C)OC2(C)C)=C1[O-].[Cl-],environment,Tc,,22,scheme 21,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C37,NOET,CCON(CC)C(=S)[S-].CCON(CC)C(=S)[S-].[N-3],environment,Tc,,23,scheme 22,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C38,PHEDTC,O=C(O[Na])C(Cc1ccccc1)NC(=S)[S-].O=C(O[Na])C(Cc1ccccc1)NC(=S)[S-].[N-3],environment,Tc,,23,scheme 22,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C39,,CC12CCC3c4ccc(O)cc4CCC3C1CCC2(O)c1cn(CC(NC(=S)[S-])C(=O)O)nn1.CC12CCC3c4ccc(O)cc4CCC3C1CCC2(O)c1cn(CC(NC(=S)[S-])C(=O)O)nn1.[N-3],environment,Tc,,23,scheme 23,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C40,,[Cl-].[Cl-].[Cl-].[N-2]c1ccc(F)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1,environment,Tc,,24,scheme 24,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C41,,Nc1ccccc1P(c1ccccc1)c1ccccc1.Nc1ccccc1P(c1ccccc1)c1ccccc1.[Cl-].[N-]=O,environment,Tc,,24,scheme 24,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C42,,F[P-](F)(F)(F)(F)F.Nc1ccccc1P(c1ccccc1)c1ccccc1.Nc1ccccc1P(c1ccccc1)c1ccccc1.[Cl-].[N-]=O,environment,Tc,,24,scheme 24,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C43,PHEDTC,O=C(O[Na])C(Cc1ccccc1)NC(=S)[S-].O=C(O[Na])C(Cc1ccccc1)NC(=S)[S-].[O-2],environment,Tc,,26,scheme 25,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C44,DGDTC,OCC1OC(O)C(NC(=S)[S-])C(O)C1O.OCC1OC(O)C(NC(=S)[S-])C(O)C1O.[O-2],environment,Tc,,26,scheme 25,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C45,MNXT,Cc1ncc([N+](=O)[O-])n1CCOC(=S)[S-].Cc1ncc([N+](=O)[O-])n1CCOC(=S)[S-].[O-2],environment,Tc,,26,scheme 25,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C46,,O=P(O[Na])(O[Na])C(O)(CCCNC(=S)[S-])P(=O)(O[Na])O[Na].O=P(O[Na])(O[Na])C(O)(CCCNC(=S)[S-])P(=O)(O[Na])O[Na].[N-3],environment,Tc,,27,scheme 26,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C47a,,C[N-]Cc1cn(CCn2c([N+](=O)[O-])cnc2C)nn1.[C-]#[O+].[C-]#[O+].[C-]#[O+].[O],environment,Tc,,27,scheme 27,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C47b,,Cc1ncc([N+](=O)[O-])n1CCn1cc(CNC(=O)[O-])nn1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,27,scheme 27,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C48,,COC(=O)Cn1cc(CNc2ccccc2[O-])nn1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,27,scheme 27,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C50a,,N=C(N)NCc1cccc(CN(CC(=O)[O-])CC(=O)[O-])c1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,29,scheme 28,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C50b,,N=C(N)NCc1cccc(CN(CCN)CC(=O)[O-])c1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,29,scheme 28,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C51,,NC(Cc1cn(C2OC(CO)C(O)C(O)C2O)nn1)C(=O)[O-].[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,30,scheme 29,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C52,,N=C(N)NCCCC1NC(=O)CNC(=O)C(CC(N)=O)NC(=O)C(N)CSSCC(C(=O)NC(CCCCn2cc(CC(N)C(=O)[O-])nn2)C(=O)NCC(N)=O)NC1=O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,30,scheme 29,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C53a,,O=C([O-])CN(CC(=O)[O-])CP(=O)([O-])[O-].[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,30,scheme 29,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C53b,,O=C([O-])CN(CC(=O)[O-])CP(=O)([O-])[O-].[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,30,scheme 29,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C54,,O=C([O-])C1([O-])CCN(CCC#Cc2cncc(OCC3CCN3)c2)CC1=O.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,31,scheme 30,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C55a,,NC(CC(=O)[O-])c1cn(CCCCCCCC(=O)O)nn1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,31,scheme 30,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C55b,,NC(CC(=O)[O-])c1cn(CCCCCCCCCCC(=O)O)nn1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,31,scheme 30,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C55с,,NC(CC(=O)[O-])c1cn(CCCCCCCCCCCCCCC(=O)O)nn1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,31,scheme 30,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,С56,,O=C([O-])c1ccccn1.[C-]#[O+].[C-]#[O+].[C-]#[O+].c1ccncc1,environment,Tc,,32,scheme 31,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,С57,,CC12CCC3c4ccc(O)cc4CCC3C1CCC2(O)c1cn(CC([NH-])C(=O)[O-])nn1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,32,scheme 31,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,С58a,,CN(C)c1ccc2nc(-c3ccc(OCCCCN(CC(=O)[O-])CC(=O)[O-])cc3)cnc2c1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,32,scheme 31,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,С58b,,CN(C)c1ccc2nc(-c3ccc(OCCCN(CC(=O)[O-])CC(=O)[O-])cc3)cnc2c1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,32,scheme 31,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,С58c,,CN(C)c1ccc2ncc(-c3ccc(OCCCCN(CC(=O)[O-])CC(=O)[O-])cc3)nc2c1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,32,scheme 31,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,С58d,,CN(C)c1ccc2ncc(-c3ccc(OCCCN(CC(=O)[O-])CC(=O)[O-])cc3)nc2c1.[C-]#[O+].[C-]#[O+].[C-]#[O+],environment,Tc,,32,scheme 31,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C59,,[C-]#[N+]Cc1ccccc1.[C-]#[O+].[C-]#[O+].[C-]#[O+].[S-]c1ccccn1,environment,Tc,,33,scheme 32,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C60a,,CNC(=S)NN=Cc1ccc([N+](=O)[O-])o1.[C-]#[O+].[C-]#[O+].[C-]#[O+].[O],environment,Tc,,33,scheme 32,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C60b,,CCNC(=S)NN=Cc1ccc([N+](=O)[O-])o1.[C-]#[O+].[C-]#[O+].[C-]#[O+].[O],environment,Tc,,33,scheme 32,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C60c,,O=[N+]([O-])c1ccc(C=NNC(=S)Nc2ccccc2)o1.[C-]#[O+].[C-]#[O+].[C-]#[O+].[O],environment,Tc,,33,scheme 32,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C61,,[N-3].[c-]1ccccc1.[c-]1ccccc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1,environment,Tc,,33,scheme 33,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C62,,CC1(C)OC(C)(C)C(C=NCCN=CC2=C([O-])C(C)(C)OC2(C)C)=C1[O-].COCCCP(CCCOC)CCCOC.COCCCP(CCCOC)CCCOC,environment,Tc,,34,scheme 34,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C63,,O=C([O-])C(F)(F)F.[N-]=O.c1ccc(P(CCP(c2ccccc2)c2ccccc2)c2ccccc2)cc1.c1ccc(P(CCP(c2ccccc2)c2ccccc2)c2ccccc2)cc1,environment,Tc,,34,scheme 34,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C64,(t/T)HYNIC-DG,O=C([O-])CNC([O-])(O)CO.O=S(=O)(O[Na])c1ccc(P(c2cccc(S(=O)(=O)O[Na])c2)c2cccc(S(=O)(=O)O[Na])c2)cc1.[N-2]Nc1ccc(C(=O)NC2C(O)OC(CO)C(O)C2O)cn1,environment,Tc,,35,scheme 35,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C67,,COCCCN(CCP(CCOC)CCOC)CCP(CCOC)CCOC.N=C(N)NCCC1NC(=O)NC(=O)C(CCCNC(=O)C2CCN(C(=S)[S-])CC2)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(=O)O)NC(=O)CNC1=O.[N-3],environment,Tc,,36,scheme 36,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C69,,CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)O)NC(=O)C[N-]C(=O)C[N-]C(=O)C[N-]C(NC([S-])N(CC)CC)c1ccccc1)C(C)C)C(=O)NC(Cc1c[nH]cn1)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)O,environment,Tc,,38,scheme 38,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C70-111,,CN(C)c1ccc(-c2cnc3cc(OCCCN(CC[S-])CC[N-]CC[S-])ccc3n2)cc1.[O-2],environment,Tc,,38,scheme 39,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C70-112,,CNc1ccc(-c2cnc3cc(OCCCN(CC[S-])CC[N-]CC[S-])ccc3n2)cc1.[O-2],environment,Tc,,38,scheme 39,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C70-113,,Nc1ccc(-c2cnc3cc(OCCCN(CC[S-])CC[N-]CC[S-])ccc3n2)cc1.[O-2],environment,Tc,,38,scheme 39,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C72-R1,,CCOCCN(CCP(CCOCC)CCOCC)CCP(CCOCC)CCOCC.O=C(Cn1cnc([N+](=O)[O-])n1)NC(C[S-])C(=O)[O-].[N-3],environment,Tc,,39,scheme 41,1,title,,
shahzad2021,10.1515/revic-2020-0021,10.1515/revic-2020-0021,0,Recent advances in the synthesis of (<sup>99m</sup>Technetium) based radio-pharmaceuticals,Walter de Gruyter GmbH,2021,0,C72-R2,,CCOCCCP(CCCOCC)CCN(CCOCC)CCP(CCCOCC)CCCOCC.O=C(Cn1cnc([N+](=O)[O-])n1)NC(C[S-])C(=O)[O-].[N-3],environment,Tc,,39,scheme 41,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,,O.O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,environment,Lu,,7,figure 3,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,NTA,O=C(O)CN(CC(=O)O)CC(=O)O,ligand,Lu,"12,5",8,figure 4,1,title,8,table 4
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,EDTA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Lu,"19,8",8,figure 4,1,title,8,table 4
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Lu,"22,4",8,figure 4,1,title,8,table 4
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Lu,"25,4",8,figure 4,1,title,8,table 4
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DO3A,O=C(O)CN1CCNCCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Lu,23,8,figure 4,1,title,8,table 4
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,NOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Lu,"15,3",8,figure 4,1,title,8,table 4
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,pSCN-Bn-DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)C(Cc2ccc(N=C=S)cc2)CN(CC(=O)O)CC1,ligand,Lu,,15,figure 12,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DOTA-NHS-ester,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)ON2C(=O)CCC2=O)CCN(CC(=O)O)CC1,ligand,Lu,,15,figure 12,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DOTAGA,O=C(O)CN1CCN(CC(=O)O)CCN(C2CCC(=O)OC2=O)CCN(CC(=O)O)CC1,ligand,Lu,,15,figure 12,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,pSCN-Bn-DTPA,O=C(O)CN(CCN(CC(=O)O)CC(Cc1ccc(N=C=S)cc1)N(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 12,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,1B4M-DTPA,CC(C(Cc1ccc(N=C=S)cc1)N(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 12,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,,O=C(O)CN(CCN(CC(=O)O)CC(Cc1ccc([N+](=O)[O-])cc1)N(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 13,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,,CC(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(Cc1ccc([N+](=O)[O-])cc1)N(CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 13,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,,CC(CN(CC(=O)O)CC(Cc1ccc([N+](=O)[O-])cc1)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 13,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,,O=C(O)CN(CCN(CC(=O)O)C(Cc1ccc([N+](=O)[O-])cc1)CN(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 13,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,CHX-B,O=C(O)CN(CC(=O)O)C(Cc1ccc([N+](=O)[O-])cc1)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 13,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,CHX-A,O=C(O)CN(CC(=O)O)C(Cc1ccc([N+](=O)[O-])cc1)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 13,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,CHX-DTPA,O=C(O)CN(CCN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 13,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DTPA,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,ligand,Lu,,15,figure 13,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,BFCA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)NCC(=O)NCC(=O)NCC(=O)NC(Cc2ccc(N=C=S)cc2)C(=O)O)CCN(CC(=O)O)CC1,ligand,Lu,,16,figure 14,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,MeO-DOTA,COc1ccc(N=C=S)cc1CC(C(=O)O)N1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Lu,,16,figure 15,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,NHS-DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)ON2C(=O)CCC2=O)CCN(CC(=O)O)CC1,ligand,Lu,,16,figure 15,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,1B4M,CC(CN(CC(=O)O)CC(Cc1ccc(N=C=S)cc1)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Lu,,16,figure 15,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DOTA-8-Aoc-BBN[7−14]NH2,CSCCC(NC(=O)C(CC(C)C)NC(=O)C(Cc1cnc[nH]1)NC(=O)CNC(=O)C(NC(=O)C(C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCC(N)=O)NC(=O)CCCCCCCNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1)C(C)C)C(N)=O,ligand,Lu,,20,figure 17,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,AMBA,C=C(CNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1)Cc1ccc(C(=O)NC(CCC(N)=O)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(C)C(=O)NC(C(=O)NCC(=O)NC(Cc2cnc[nH]2)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(N)=O)C(C)C)cc1,environment,Lu,,20,figure 18,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,RGD-dimer,N=C(N)NCCCC1NC(=O)C(CCCCNC(=O)CCC(NC(=O)N2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)C(=O)NCCCCC2NC(=O)C(Cc3ccccc3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC2=O)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(=O)O)NC(=O)CNC1=O,ligand,Lu,,22,figure 21,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,RGD2,N=C(N)NCCCC1NC(=O)C(CCCCNC(=O)CCC(N)C(=O)NCCCCC2NC(=O)C(Cc3ccccc3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC2=O)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(=O)O)NC(=O)CNC1=O,ligand,Lu,,22,figure 21,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DOTA-RGD2,N=C(N)NCCCC1NC(=O)C(CCCCNC(=O)CCC(NC(=O)N2CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC2)C(=O)NCCCCC2NC(=O)C(Cc3ccccc3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC2=O)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(=O)O)NC(=O)CNC1=O,environment,Lu,,22,figure 21,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DOTA-Bz-RGD2,N=C(N)NCCCC1NC(=O)C(CCCCNC(=O)CCC(NC(=S)Nc2ccc(C3CN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN3C(=O)[O-])cc2)C(=O)NCCCCC2NC(=O)C(Cc3ccccc3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC2=O)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(=O)O)NC(=O)CNC1=O,environment,Lu,,22,figure 21,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DTPA-Bz-RGD2,N=C(N)NCCCC1NC(=O)C(CCCCNC(=O)CCC(NC(=S)Nc2ccc(C3CN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN3CC(=O)[O-])cc2)C(=O)NCCCCC2NC(=O)C(Cc3ccccc3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC2=O)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(=O)O)NC(=O)CNC1=O,environment,Lu,,22,figure 21,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,TA-138,Cc1cc(OCCCC(=O)NCCNC(=O)C(NC(=O)C(NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)S(=O)(=O)O)S(=O)(=O)O)cc(C)c1S(=O)(=O)NC(CNC(=O)c1c[nH]c2ccc(CNc3ncc[nH]3)cc2c1=O)C(=O)O,ligand,Lu,,23,figure 22,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,,Nc1nc2ncc(CNc3ccc(C(=O)NC(CCC(=O)NCCCCn4cc(CNC(=O)CN5CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC5)nn4)C(=O)O)cc3)nc2c(=O)[nH]1,ligand,Lu,,23,figure 25,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,EDTMP,O=P(O)(O)CN(CCN(CP(=O)(O)O)CP(=O)(O)O)CP(=O)(O)O,ligand,Lu,,25,figure 26,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,PDTMP,O=P(O)(O)CN(CCCN(CP(=O)(O)O)CP(=O)(O)O)CP(=O)(O)O,ligand,Lu,,25,figure 26,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,BDTMP,O=P(O)(O)CN(CCCCN(CP(=O)(O)O)CP(=O)(O)O)CP(=O)(O)O,ligand,Lu,,25,figure 26,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DMPDTMP,CC(C)(CN(CP(=O)(O)O)CP(=O)(O)O)CN(CP(=O)(O)O)CP(=O)(O)O,ligand,Lu,,25,figure 26,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DTPMP,O=P(O)(O)CN(CCN(CP(=O)(O)O)CP(=O)(O)O)CCN(CP(=O)(O)O)CP(=O)(O)O,ligand,Lu,,25,figure 26,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,TTHMP,O=P(O)(O)CN(CCN(CCN(CP(=O)(O)O)CP(=O)(O)O)CP(=O)(O)O)CCN(CP(=O)(O)O)CP(=O)(O)O,ligand,Lu,,25,figure 26,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,CTMP,O=P(O)(O)CN1CCCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CCCN(CP(=O)(O)O)CC1,ligand,Lu,,25,figure 26,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,DOTMP,O=P(O)(O)CN1CCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CC1,ligand,Lu,,25,figure 26,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,Estradiol−DOTA,CC12CCC3c4ccc(O)cc4C(NC(=S)Nc4ccc(CC5CN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN5CC(=O)O)cc4)CC3C1CCC2O,ligand,Lu,,27,figure 28,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,Porphyrin−DOTA,O=C(O)COc1ccc(C2=C3C=CC(=N3)C(c3ccc(OCC(=O)O)cc3)=c3ccc([nH]3)=C(c3ccc(OCC(=O)O)cc3)C3C=CC(=C(c4ccc(OCC(=O)Nc5ccc(CC6CN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN6CC(=O)O)cc5)cc4)c4ccc2[nH]4)N3)cc1,ligand,Lu,,27,figure 29,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,Metronidazole-p-aminobenzyl DOTA,Cc1ncc([N+](=O)[O-])n1CCOC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,ligand,Lu,,28,figure 30,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,derivative-p-amino-DOTA-anilide,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)Nc2ccc(NC(=O)CCNC(=O)Cn3cncn3)cc2)CCN(CC(=O)O)CC1,ligand,Lu,,28,figure 31,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,BPAMD,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)NC(P(=O)(O)O)P(=O)(O)O)CCN(CC(=O)O)CC1,ligand,Lu,,33,figure 36,1,title,,
banerjee2015,10.1021/cr500171e,10.1021/cr500171e,0,"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications",American Chemical Society (ACS),2015,0,,texaphyrin,CC(=O)[O-].CC(=O)[O-].CCc1c(CC)c2cc3nc(cnc4cc(OCCOCCOCCOC)c(OCCOCCOCCOC)cc4ncc4nc(cc1[nH]2)C(CCCO)=C4C)C(C)=C3CCCO,environment,Lu,,35,figure 39,1,title,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,3a,p-SCN-Bn-5p-C-NETA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(CCCCCc2ccc(N=C=S)cc2)N(CC(=O)O)CC(=O)O)CC1,ligand,Lu,,6,figure 3,3,subtitle,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,3b,p-SCN-Bn-DOTA,O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)C(Cc2ccc(N=C=S)cc2)CN(CC(=O)O)CC1,ligand,Lu,,6,figure 3,3,subtitle,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,3c,p-SCN-Bn-H4octapa,O=C(O)CN(Cc1cccc(C(=O)O)n1)CC(Cc1ccc(N=C=S)cc1)N(CC(=O)O)Cc1cccc(C(=O)O)n1,ligand,Lu,,6,figure 3,3,subtitle,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,3d,p-SCN-Bn-CHX-A''-DTPA,O=C(O)CN(CC(=O)O)C(Cc1ccc(N=C=S)cc1)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Lu,,6,figure 3,3,subtitle,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,,CHX-A′-DTPA,O=C(O)CN(CC(=O)O)C(Cc1ccc(N=C=S)cc1)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Lu,,7,figure 4,3,subtitle,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,,CHX-A′′-DTPA,O=C(O)CN(CC(=O)O)C(Cc1ccc(N=C=S)cc1)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Lu,,7,figure 4,3,subtitle,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,,CHX-B′-DTPA,O=C(O)CN(CC(=O)O)C(Cc1ccc(N=C=S)cc1)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Lu,,7,figure 4,3,subtitle,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,,CHX-B′′-DTPA,O=C(O)CN(CC(=O)O)C(Cc1ccc(N=C=S)cc1)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O,ligand,Lu,,7,figure 4,3,subtitle,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,,1B4M-DTPA,CC(CN(CC(=O)O)CC(Cc1ccc(N=C=S)cc1)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Lu,,7,figure 4,3,subtitle,,
sarbisheh2019,10.1007/978-3-319-98947-1_20,10.1007/978-3-319-98947-1_20,0,The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium,Springer International Publishing,2019,0,,DTPA,CC(CN(CC(=O)O)CC(Cc1ccc(N=C=S)cc1)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,ligand,Lu,,7,figure 4,3,subtitle,,
